Start with what the week was for.

The method, and why it transfers

Everything this week came out of documents anyone can download, for nothing, without a subscription or a terminal.

The cash flow statement. The annual report. The results release. The proxy. An earnings call transcript. That is the entire toolkit, and the tests run on it are arithmetic rather than judgment: divide this by that, put the answer next to the trading range, read the paragraph the chief executive wrote freely, count what changed.

None of this requires an opinion about a business. It requires the patience to open eight filings instead of one.

That is the transferable part, and it is why the specific company matters less than the sequence.

What they were good at

Start where the evidence is strongest, because a review that only finds faults is not a review.

This management team ran the business well. Revenue roughly quadrupled over the departing chief executive’s tenure. In fiscal 2022 the company earned $854.8 million on stockholders’ equity of $3.15 billion, a return on equity near 27%, which is a level most large companies never reach. Gross margin sits above 60%. The brand became strong enough that walking past a store tells you nothing is obviously wrong.

What that tells you: the operating half of the job was done properly. Product, stores, brand, people. Whatever went wrong later did not go wrong because nobody could run a shop.

That matters for what follows, because the rest of this is not a story about incompetence.

What they were expensive at

The other half of a chief executive’s job is deciding where the money goes, and this is where the record separates.

They bought one company and wrote most of it off. MIRROR cost $500 million in 2020. By the fourth quarter of fiscal 2022 it had been written down by $442.7 million after tax. The company had disclosed the goodwill risk itself, in the annual report filed in March 2021, along with the observation that its management had limited experience in that area.

They bought their own stock as it got more expensive. Across fiscal 2021 to 2025, 15.2 million shares for about $4.62 billion, an average near $304. The stock traded below $100 last week. The largest single year, $1.6 billion in fiscal 2024, came at the second-highest price of the whole series.

And the capital base test confirms it from the owner’s side. Between fiscal 2024 and 2025 the share count fell 3.9% while earnings per share fell 9.4%. The buybacks were pushing that number up and it went down anyway.

One fact cuts the other way and belongs here. Through the most recent half, with sales at existing stores falling 9%, the company opened nine net new stores. It also cut planned net new openings for the year from 40 to 35, and pop-ups from 65 to about 40, publicly and with a reason. A team under pressure that reduces its own expansion plan is doing the harder thing.

What that tells you: two different skills, and this team had one of them. A 27% return on equity says the business converts capital into profit efficiently. Paying $369 a share for that business in 2021 was a separate decision, made by the same people.

That distinction is the single most useful thing a run of annual reports will give you, and it is invisible in any one year.

The announcement, and what it did not say

One document from that acquisition is worth reading closely, because it teaches something that outlasts this company.

The 8-K filed on 29 June 2020 says the purchase will advance the company’s strategic vision by strengthening its omni guest experiences through digital sweat, and will bolster its digital sweatlife offerings.

Two phrases there need translating. Omni guest experiences is retail for selling to the same person through more than one channel: shop, website, app, and now a screen on their wall. The sweatlife is the company’s own coined term for its customer’s life around exercise.

Strip both out and the strategy underneath is coherent, and I want to be fair about that. We sell clothes to people who exercise. Today we see them when they need leggings. If we sell them the workout, we are in their house every day and a subscription pays us monthly rather than occasionally. That is a real idea, and Peloton had shown the model could work.

So the purchase was not frivolous in concept. The questions sit elsewhere: $500 million for a business launched two years earlier whose own forecast for that year was $100 million, bought while gyms were shut and home fitness was among the most crowded trades in retail.

And here is what the announcement does not contain. A number. No expected return on the $500 million. No payback period. No revenue or margin target. The only financial expectation attached to the deal that day came in a television interview rather than in the filing.

So a test, and it takes two minutes on any acquisition announcement. Translate the jargon into plain language, then ask what the rationale promises in figures.

The translation matters as much as the figures, because jargon is not merely ugly. It is untestable. “We expect to convert 5% of our guests to a $39 a month subscription” is a sentence you can check in two years. “Deepen our roots in the sweatlife” is a sentence nobody can ever be wrong about.

A rationale you cannot translate into a checkable claim is a rationale nobody can be held to. That is the warning, and it is separate from whether the strategy is any good.

What they said about it

A record tells you what happened. The account tells you how a team handles what happened, and those are separate pieces of evidence.

The forecast. At the acquisition, more than $100 million of revenue that year and break-even the next. Raised to more than $150 million. Raised again to $250-275 million. Cut to $125-130 million. Then written off. It rose twice before it fell, which means confidence increased while the evidence was turning.

The description. At the purchase, the business was fuelling the company’s growth plan. Explaining the write-off, the finance chief called it a very small portion of management’s five-year plan. Same business, same team, the stated importance falling with the value.

The statement. In the release carrying a $442.7 million write-off, the chief executive’s own paragraph described strong results, continued high performance and enduring brand strength. The impairment was disclosed elsewhere in that release and he named it on the call when asked. It is not in the paragraph he chose the words for.

What that tells you: nothing improper, and a consistent preference. Given a choice about emphasis, this team took the favourable one, every time, in the places where the choice was theirs to make.

The three I could not settle

Three tests did not produce a clean answer, and in each case the reason is worth more than the result would have been.

Is the decline the industry’s or the company’s. Inconclusive, because four of the six companies competing for this customer are private and file nothing. The one comparable public business, Athleta, fell exactly the same 12%. What would settle it: filings that do not exist. If you hear someone state confidently that Lululemon is losing share to Vuori or Alo, ask where the number came from.

Did they ever act on a limit, at a cost. Not proven. Form 8-K Item 5.02 records senior arrivals and departures within four business days, and it gives who and when but never why, because the SEC considered requiring reasons and dropped it over defamation risk. What would settle it: an appointment where a leader hands a function to someone who has fixed that exact problem elsewhere, read alongside the letter that explains it.

Owner earnings. Retired. The method is to treat depreciation as maintenance spending and capital spending above it as growth. On this company it does not hold: between $167 million and $183 million a quarter went into a distribution centre project, new stores, relocations, renovations and technology, and a relocation is maintenance and growth at once. What would settle it: a business with a stable asset base, where the proxy works. Not this one, not this year.

Not proven is a verdict, not a gap. It means the evidence does not exist, rather than that it came back against them, and treating those as the same thing is how a framework starts convicting people for being new.

So how do I read this management team

Competent operators who were poor at the part of the job that compounds.

That is not a soft verdict and it is not a harsh one. It is the specific finding that emerges from reading the filings in sequence rather than one at a time, and it is worth being precise about why it matters.

A business earning 27% on equity throws off cash. What happens to that cash is the whole question, because over ten years it becomes most of what you own. Buffett’s arithmetic puts it at more than 60% of all capital in the business after a decade at modest retention rates. This team put $4.62 billion of it into their own shares at roughly three times today’s price, and $500 million into an acquisition that was written down by $442.7 million after tax.

The operating skill built the cash. The allocation decisions are what happened to it.

And the account they gave has a consistent shape. Forecasts revised upward before they were cut. A business described as central on the way in and peripheral on the way out. A write-off disclosed where required and absent from the paragraph written freely. None of it improper. All of it in the same direction.

That direction is the finding. One favourable choice is a coincidence. Three separate ones, across three different documents, over three years, is a disposition. And a disposition is the thing you can expect to continue, because it is the part that does not depend on the business.

What Buffett’s own criteria would say

Last Monday I started with the list Berkshire printed in the back of its annual report for years, because it is the shortest honest statement of what a buyer of whole businesses wants. It is worth finishing the week by running this company against it.

Demonstrated consistent earning power. Passed, historically. Revenue quadrupled, margins were strong for a decade, the record is real. But the same criterion says future projections are of no interest and, in the same breath, no turnaround situations. That is the sentence that bites. A business with comparable sales falling 12% in its largest market, a category shifting underneath it, and a new chief executive brought in to fix it is a turnaround, whatever else it is.

Good returns on equity while employing little or no debt. Passed, and comfortably. A return on equity near 27%, and the balance sheet carries no borrowings under its credit facility.

Management in place. This is the one the whole week has been about, and the answer is the most interesting of the three. The criterion exists because Buffett does not want to supply management. He is buying a team as much as a business. A company that changed chief executive last Tuesday has management in place in the literal sense and not in the sense the criterion means, which is a team whose record you can read.

So the verdict against that list is clean and it is not close. The economics pass. The turnaround exclusion fails. And the management criterion returns the same answer this week has returned throughout: not yet knowable.

That is not a reason to walk away. It is a reason to know which question you are waiting on. Most of what has been written about this company since the announcement is about whether the new leader is the right choice. The criterion says something narrower and more useful: you cannot know yet, and here is what would tell you.

What a change of management does to a review

This is the part I would want if I were reading rather than writing, because the situation is more common than it looks. Somebody leaves, somebody arrives, and every review written in that window is confused about which record it is describing.

Some tests survive a change and some reset.

The business does not change when the chief executive does. Return on capital, gross margin, the strength of the category, the balance sheet, the competitive set. All of that is still true on Wednesday. Everything I found about this business survives the transition intact.

Everything about the people resets to zero. The allocation record, the candour record, the forecasting record, the trait. Not to a bad score. To no score.

The departing record becomes the bar, not the verdict. This is the distinction that took me most of the week to say properly. Calvin McDonald’s capital decisions tell you nothing about Heidi O’Neill. What they tell you is what a good outcome and a poor one look like at this specific company, which is the yardstick you hold up to whatever she does next.

And a transition hands you something you do not usually get. A new chief executive has an incentive that a continuing one does not: problems named early in a tenure belong to a predecessor, and problems named later belong to her. Write-downs, restructurings and honest disclosures cluster early in a tenure for exactly that reason.

Which cuts both ways, and you should know both.

The favourable reading is that you are about to learn more about this business in two quarters than the previous two years disclosed, because it is temporarily in her interest to tell you.

The unfavourable reading is that the same incentive makes early candour cheap. Naming a problem you did not create costs nothing. The test that matters is the second one, when the problem is hers.

That is why the watchlist below runs on documents rather than on the next few months of announcements.

Why this matters if you invest for yourself

Because it is the part of the work that nobody does for you.

Analyst coverage will tell you what the business might earn next year. Nothing in it will tell you what this team did with $4.62 billion, whether they raised a forecast before cutting it, or whether they named a loss in the paragraph they wrote themselves. Those are all knowable, all free, and all sitting in documents that require nothing but the patience to open them.

A self-directed investor’s real advantage is not better information. It is being willing to read the boring documents that contain it.

There is a second advantage, and it is the one this week was really about. You can do this before the price moves. Everything here was available months ago. None of it required knowing what the stock would do. When a price does fall far enough to interest you, the management work is either already done or it is being done in a hurry, and hurried work is how people talk themselves into things.

What happens next

Heidi O’Neill started on Tuesday. She has run this company for days, and nothing in this week’s evidence is hers. I am not going to grade her on a record she did not make.

What I will do is watch four documents.

The next results release, and specifically the paragraph attributed to her. Does it name what is not working, in the quarter it happens.

The next repurchase disclosure. About $713 million of authorisation remains and the company has said it expects to keep buying at 2025 levels. The test is not the amount. It is the average price, which is the cost divided by the change in share count, and it appears in the same paragraph every time.

Her first proxy statement, which will set out the terms of her arrangement: what vests on a change of control, what severance looks like, and how much of her pay depends on results that have already happened.

The 8-K stream, for who she hires and what she gives up to get them. The record will not say why, but it will say who and when, and if she brings in someone who has fixed this exact problem elsewhere, that is a decision with a cost attached.

Those four are dated, filed and free. Between them they would answer most of what this week could not.

And one thing this week did not touch at all. I have not valued this business. Everything above is one test of several, run deliberately in isolation so that a falling price could not make the evidence look better than it is. Whether the price is attractive is separate work, and if I do it, it will be its own week with its own standard of proof.

Which leaves the honest summary of six days, in a sentence.

A good business, run well and allocated badly, handed to someone with no record at it, at a price that has fallen far enough to make all of that worth knowing.

Three of those four things I can tell you from filings. The fourth arrives over the next year, in documents that are already scheduled.

Not investment advice. The subscriber decides.

Yesterday I said a record tells you how a team behaved but not whether the behaviour is still happening. Before I get to that, the record needs to be complete.

Why one year was not enough

On Wednesday I showed you a single number: 2.2 million shares bought during fiscal 2021 at an average of $369.16, for $812.6 million.

On its own that tells you very little, and I want to be careful about why.

Fiscal 2021 was an excellent year for the business. Revenue grew sharply, the brand was strong, and the shares had risen because the results deserved it. Nothing about the year was bad. What was expensive was the price paid for the stock, and any company can pay a high price once.

What a single year cannot tell you is whether that was a slip or a method, and the difference is everything. So I went back through the annual reports and pulled the same two figures out of each one: how many shares they bought, and what they paid.

Both numbers sit in the Financing Activities paragraph of the annual report, which is where a company explains what it did with cash. Divide the second by the first and you have the average price paid. It is the arithmetic from Wednesday, run ten times.

Eleven years, six filings

Here is what came out, with the implied average alongside.

In fiscal 2015 the company bought 5.0 million shares for $274.2 million, about $55 each. In 2016, 0.5 million shares for $29.3 million, about $59. In 2017, 1.9 million for $100.3 million, about $53.

Then the price of the shares began to climb, and so did the buying.

In 2018, 4.9 million shares for $598.3 million, about $122. In 2019, 1.1 million for $173.4 million, about $158. In 2020, 0.4 million for $63.7 million, about $159.

In 2021, 2.2 million shares for $812.6 million. The company disclosed that average directly: $369.16.

In 2022, 1.4 million shares for $444.0 million, about $317. In 2023, 1.5 million for $558.7 million, about $372. In 2024, 5.1 million shares for $1.6 billion, about $314. In 2025, 5.0 million shares for $1.2 billion, about $240.

The company spent more on its own stock in fiscal 2024 than in any other year in the series, at a price close to six times what it paid in 2017.

And fiscal 2025 is the year worth stopping on. That was Calvin McDonald’s last full year. Americas comparable sales fell 3%. Operating margin fell 380 basis points to 19.9%. Earnings per share fell from $14.64 to $13.26.

The company spent $1.2 billion buying its own stock during it.

Three things about those numbers before anyone builds a case on them. From fiscal 2022 onward the reported cost includes commissions and excise taxes, so the implied price is slightly higher than the true purchase price. The share counts are rounded to a tenth of a million, which makes the smallest years imprecise, and I have marked those approximate. And fiscal 2025 comes from the most recent annual report and the full-year results release, both of which state the same figures.

The five years that matter

Take fiscal 2021 through 2025 together. Five full years, each from the same paragraph of an annual report.

15.2 million shares. About $4.62 billion. An average of roughly $304 each.

The stock traded below $100 last week.

Buying accelerated as the price rose. That is the sentence, and it is arithmetic rather than opinion.

What I am not saying

I am not saying the shares were worth less than $304 when they were bought. Nobody can establish that from outside a company, and I would be pretending to knowledge I do not have.

In 2021 and 2024 this was a business growing revenue at double digits, throwing off cash, with a brand that looked untouchable. Even in 2025 revenue still grew 5%. Buying your own stock in that situation is a defensible decision and thousands of management teams make it.

Nor am I saying returning cash to owners is wrong. It is one of the five things a company can do with a dollar, and often the best one.

What I am saying

Last week I set out the test that decides whether a repurchase helped the owners who stayed. Two conditions, both required. The company has funds beyond what the business needs. And the stock is selling at a material discount to what it is conservatively worth.

The first condition looks comfortably met in the years I pulled: this was a business generating cash with a strong balance sheet throughout. The second is the one that gets skipped, and it is skipped in a specific way: a rising share price feels like confirmation that the business is working, which makes buying feel prudent exactly when it is most expensive.

A buyback is the only capital decision where the price is public before you make it. Which means it is the only one where getting the price wrong is a choice rather than an accident.

That is what a run of filings tells you and a single year does not. In 2023 the company paid its highest average price of the series, about $372. In 2024 it spent $1.6 billion, more than in any other year. In 2025, with the Americas already shrinking and margins falling, it spent $1.2 billion more.

What the interim team did with it

Calvin McDonald left at the end of January. Meghan Frank and André Maestrini have run the company since, and the quarter reported on 3 September is theirs.

In that quarter, the company repurchased 2.7 million shares for $330.0 million. That is about $122 a share, computed the same way.

It is the lowest average price paid since fiscal 2018, and it is still above where the stock traded a fortnight later.

In the same quarter they opened nine net new stores, ending with 825 against 784 a year earlier, and spent $149.7 million on capital projects. Then they cut the full-year outlook for the second quarter running.

On the call, the company said repurchases remain its preferred method of returning cash and that it expects 2026 buyback levels in line with 2025.

They committed to keep buying in the same breath as they told investors the business would be smaller than they thought.

The thing they did decline

One test from last week is what a management team says no to, and this one said no to something.

Net new store openings for the year were cut from 40 to 35. Pop-up stores were cut from 65 to about 40. Both were announced publicly with a reason attached.

That is a real mark in their favour and it belongs here. A team under pressure that reduces its own expansion plan is doing the harder thing, and I would rather report it than leave it out because it complicates the argument.

The bar

Which brings me to the person who started on Tuesday.

Heidi O’Neill has run this company for days. Nothing in this week’s evidence is hers, and grading her on it would be the error I warned about on Monday. What the evidence does is set the height of the bar, and the bar has three parts.

Capital discipline, measured by price rather than by amount. The company has roughly $713 million of repurchase authorisation remaining and has said it intends to use it. Whether that is a good decision depends entirely on what it pays. If the next annual report shows a large sum spent at a price that later looks high again, nothing has changed. That is checkable, it is dated, and it appears in the Financing Activities paragraph where the rest of this series came from.

The core category, which the company itself named. In the last quarter the company reported a greater-than-expected slowdown in core categories and named leggings specifically. This is not a cost problem or a store problem. Comparable sales in the Americas fell 12% because fewer people came in, fewer of those bought, and the ones who bought spent less. That is a product and brand problem, and it is the one thing on this list that cannot be fixed by allocating capital better.

The account, when the next thing goes wrong. Something will. What this week established is that the record of how this company describes its own failures is mixed: the write-off was disclosed as required, acknowledged when asked, and absent from the paragraph the chief executive wrote freely. The first letter and first results release under new leadership will show whether that changes.

What getting back to good actually requires

Not growth. Growth is what a recovery looks like from outside, not what produces it.

The business still generates cash: $589.3 million from operations in the first half, against $209.7 million a year earlier, with $1.4 billion in the bank. The gross margin is intact. This is not a company fighting for survival, which is precisely why the next few decisions are worth watching. Nobody is forced into anything.

A company with $1.4 billion in cash and a falling share price is a company whose management is about to reveal what it believes.

Tomorrow

The last piece.

What can and cannot be known about the incoming chief executive, where to look for the first evidence, and the documents that will settle it, with dates.

Not investment advice. The subscriber decides.

Yesterday I set out two decisions this management team made with shareholders’ money, and said today would be the account they gave of one of them. This is that, and the account turns out to have three parts.

Start with why an old forecast is worth anything at all.

Why old forecasts are evidence when new ones are not

Berkshire’s acquisition criteria have said in print since the early 1980s that future projections are of no interest. A plan is a claim about people who have not yet done the thing.

That rule is about not trusting a forecast as evidence about a business. It says nothing about forecasts a company has already made, and those are a different document entirely. They are dated. They are specific. The outcome is known.

A projection is worthless as evidence about a business and valuable as evidence about the people who made it.

Where to find them

Old forecasts live in four places, all free. The transcript of any earnings call, usually posted on a company’s investor relations page and carried by several sites going back years. The press release attached to a results filing, where guidance is usually given in a table near the end. Investor day presentations, which contain the most specific and most forgotten numbers a company ever publishes. And the announcement of any acquisition, where a management team explains what it expects the thing to do.

Pick a decision that is at least three years old and large enough to have been discussed. Write down what they said it would do, with the date. Then find what it did.

The trail, once

Lululemon announced it was buying MIRROR on 29 June 2020, for a purchase price of $500 million.

That same day the chief executive told CNBC the business expected more than $100 million of revenue that year and would break even or be slightly profitable the next. At the results announced in September 2020 the company raised that to more than $150 million. The annual outlook was later set at $250 to $275 million. At the results announced in December 2021 it was cut to $125 to $130 million. In March 2023 the business was written down by $442.7 million after tax.

That is the sequence. Now the part that matters, which is not the miss.

Three things to look for in a revision

First, the direction as evidence arrived. A team that holds a forecast while the world moves is being stubborn. A team that raises one is telling you its confidence went up. Here the number went up twice before it came down, which means that as data accumulated through 2020 and 2021, the read got more optimistic rather than less.

That is not dishonesty. It is a question about instruments. A management team either had information that supported the raise, or it was reading its own enthusiasm. You cannot tell which from outside, and you do not have to, because the next revision tells you.

Second, the size of the correction when it came. A guidance range moving from $250 to $275 million down to $125 to $130 million is roughly a halving in a single step. Small corrections mean a team is adjusting continuously. One large correction means the gap had been open for a while before it was closed.

Third, whether the description of the decision changed. This is the one worth learning, because it is the least visible and the most telling.

The importance downgrade

When Lululemon announced the purchase, it described the acquisition as building on its vision, strengthening its omni guest experiences, and fueling the Power of Three growth plan. That is a business being placed near the center of the strategy.

When the impairment was explained, the chief financial officer described the business as a very small portion of management’s five-year plan.

Same business. Same management. Between those two statements, its stated importance to the company fell.

Watch for that. A decision that was central when it was made and peripheral when it failed has been reclassified, and the reclassification is a choice about how the record reads.

I am not saying either description was untrue. A business can be strategically central when it is bought for $500 million and marginal after $442.7 million of it has been written off. Both statements can be accurate. What the pair tells you is how this team frames a decision on the way in and on the way out, and framing is the part they control completely.

The second half of the test

You now know what a team predicted and what happened. The remaining question is what they said when the answer arrived.

Yesterday I said I would read the letter from the year the write-off landed. That needs a correction, and the correction is worth more than the original promise.

Lululemon does not publish a shareholder letter. Berkshire’s annual letter is famous partly because writing one at that length is a choice rather than a requirement, and a test built on reading one assumes a document a company may not produce. When it does not, the nearest equivalent is the paragraph attributed to the chief executive in the results release, and it does the same job for the same reason: it is the passage a management team writes freely, in a document otherwise governed by accounting rules.

When a test assumes a document a company does not produce, find the place where the same choice gets made. Do not skip the test and do not pretend the document exists.

Find the results release covering the quarter the loss landed. Skip the headline. Skip the tables. Go to the paragraph attributed to the chief executive, which is the one part of the document a management team chooses the words for, and which is the passage most likely to be quoted everywhere else.

Three outcomes, easy to tell apart. They name the loss and say what they are doing about it. They gesture at it in language general enough to describe any year. Or it is not there.

Lululemon’s release of 28 March 2023 reported fourth-quarter revenue up 30% to $2.8 billion, GAAP earnings per share of $0.94 and adjusted earnings per share of $4.40. In his statement, McDonald described strong results across the business, a continued high level of performance, the enduring strength of the brand, and optimism about sustained growth.

The impairment does not appear in that paragraph.

Being fair about this

Three things need saying and leaving them out would make the point stronger and the article worse.

The write-off was disclosed. It is in the release, in the annual report, and in a note of its own. Nobody hid anything, and under the accounting rules nobody could.

McDonald named it on the call. Asked about the quarter, he said the company was taking an impairment charge related to assets and goodwill associated with Mirror. That is an acknowledgment and it counts.

And a chief executive’s statement in a results release is a marketing document. Every company writes them the same way, and none of them lead with the bad news.

So the claim is narrow. The company disclosed what it was required to disclose, and the chief executive acknowledged it when asked. The paragraph he chose the words for did not contain it.

What all this tells you about competence

Not that the acquisition was a mistake. The write-off already told you that and it took no skill to notice.

What the exercise gives you is three readings you cannot get from the financial statements.

How they read their own information. Confidence rose for eighteen months into a category that was turning. Either the data supported that or it did not, and the size of the eventual correction is the clue.

How fast they close a gap. One halving rather than a series of trims.

How they describe a decision once it has gone wrong. Central on the way in, a very small portion on the way out, and absent from the paragraph they wrote freely.

None of those is a character judgment and none requires guessing at anyone’s motives. All three are dated, filed, and available to anyone willing to spend an afternoon.

A management team’s forecasting record is a record like any other. It is just the only one they publish about themselves in advance.

What this cannot tell you

Every document in today’s piece is at least two years old, and the person who wrote most of them left the company in January.

A record tells you how a team behaved. It does not tell you whether the behavior is still happening, and the people running this business today are not the people who bought MIRROR.

So the test has to be run again on the present, which is a harder thing to do, because the results are not in yet and the write-off has not happened.

Tomorrow: the last ninety days. The quarter reported two weeks ago, what the interim team did with the company’s money while the stock was falling, and which number carried the headline this time.

Not investment advice. The subscriber decides.

Yesterday ended on the only evidence left, so here it is. But two words in that paragraph are doing a lot of work, and they are worth ninety seconds before anything else.

Goodwill, and what it means to write it off

When one company buys another, it pays a price. Then the accountants add up what it bought: the buildings, the equipment, the inventory, the cash, the patents, anything you can point at and value on its own.

The price is almost always higher than that total.

The difference has a name. Goodwill. It is what the buyer paid above the value of the identifiable things, and it stands for everything that is not a thing: the brand, the customer list, the team, and above all what the buyer expects the business to become.

Goodwill goes onto the balance sheet as an asset, and it sits there at the price paid. It is not worn down year by year the way a delivery van is. It stays at full value until somebody decides it should not.

Goodwill is the price of a company’s expectations, recorded as an asset.

That is where the second word comes in. Accounting rules require a company to test that asset regularly and ask whether the business it bought is still worth what was paid. If the answer is no, it has to write the value down, and the write-down is called an impairment.

An impairment is not a cash payment. The money left years earlier, at the moment of purchase. What the charge does is force the company to say so on the record: we paid this much, it is not worth that, and here is the difference.

It is the accounting system making a company admit in public that it overpaid.

So when a filing says a significant portion of a purchase price was allocated to goodwill, it is telling you that most of what was bought was expectation rather than machinery. And when it says impairment charges may be required if the acquisition does not yield expected returns, it is telling you what happens if the expectation does not arrive.

Both of those sentences appear in Lululemon’s own annual report, about this acquisition, before any of it happened.

Why the cash flow statement and not the income statement

A company’s earnings tell you what a year produced. They do not tell you what anyone decided.

Every year a business keeps some of its profit rather than paying it out, and somebody chooses where that money goes. Reinvest it. Buy something. Pay down debt. Pay a dividend. Buy back stock. Those five choices, made repeatedly over years, become the company you own.

Calvin McDonald held the job from 2018 until earlier this year. That is eight years of those choices, and two of them are large enough to see from the outside without any interpretation at all.

The acquisition

In the second quarter of fiscal 2020, Lululemon acquired Curiouser Products Inc., trading as MIRROR, an in-home fitness company selling a wall-mounted screen with live and on-demand classes. The timing is worth holding. This was the middle of 2020, when in-home fitness was a category with an obvious tailwind and gyms across much of the world were shut.

By the fourth quarter of fiscal 2022, the company was running an impairment test on it. Impairment testing was completed as of 29 January 2023, and the result was $442.7 million of post-tax impairment and other charges, including $407.9 million against goodwill and other assets.

A business bought at the top of a category was written down by hundreds of millions of dollars two and a half years later. That is not unusual. What follows is.

They wrote the warning themselves

Go back to that annual report, filed in March 2021 and covering the fiscal year in which the purchase was made, and read the risk factors. Companies are required to disclose what could go wrong, and much of that section is boilerplate.

This part was not boilerplate. The filing stated that a significant portion of the purchase price had been allocated to goodwill, and that if the acquisition did not yield expected returns the company might be required to record impairment charges, which would adversely affect its results. It went on to note that its management team had limited experience in the area.

I want to be careful about what that establishes, because it is easy to overreach.

A risk factor is not a prediction. It is a list of things that could happen, drafted by lawyers, and every company files pages of them. The presence of a warning does not mean anyone expected the outcome.

But it does establish two things that matter for a management assessment.

The risk was identified, in writing, by the people who took it. Nobody can say afterwards that this came out of nowhere.

And the company said, in its own filing, that its management had limited experience in this area. That is an unusually direct statement, and it is the company’s own characterization rather than mine.

The question a management review asks is not whether a decision went wrong. It is what was known when it was made. Here, the company told us what it knew.

What it cost beyond the money

The $442.7 million is the number that gets quoted. The effect on the year is the part that shows what a write-off does to a business.

Operating income in the fourth quarter of fiscal 2022 was $314.4 million, or 11.3% of net revenue, against $590.6 million and 27.7% a year earlier. Adjusted to exclude the impairment, operating income for that quarter was $785.3 million, or 28.3%.

The company’s own annual report puts it more plainly than I could. Lululemon generated approximately 24% of its full-year operating profit in the fourth quarter of fiscal 2022. Excluding the impairment, it would have been approximately 44%.

That is a single decision, made in 2020, removing roughly twenty points of the fourth quarter’s contribution to the year’s profit in 2022.

The second decision

The other place a company’s money goes is into its own shares, and this one is measurable to the cent.

From the company’s own disclosure: during fiscal 2021, Lululemon repurchased 2.2 million of its own shares at an average price of $369.16 per share, for a total cost of $812.6 million. As at 30 January 2022 it had $187.5 million of authorization remaining, which it completed in the following quarter. In March 2022 the board approved a new program for up to $1.0 billion.

Last week the shares traded below $100.

I am not going to tell you the shares were worth less than $369 in 2021. Nobody can establish that from outside, and a management team buying stock in a business growing quickly is doing something defensible on its face.

What I can tell you is the arithmetic. $812.6 million of shareholders’ money bought 2.2 million shares at an average of $369.16. At under $100, those shares are worth roughly 27% of the average price paid.

That is not a forecast that failed. It is a purchase, and the price is a matter of record.

The test I could not finish

Tuesday I said I would run the first test from the management series on this record: whether earnings grew faster than the capital base. A business that adds to its equity every year produces rising earnings almost automatically, so growing profit on a faster-growing balance sheet is not the achievement it appears to be.

I could not assemble that from primary sources in the time I had. The revenue and earnings history is available in aggregators, and under the rule I set this week, an aggregator is a lead and not a citation. The figures I would need sit in eight separate annual reports and I have not read all eight.

So I am not going to give you a return-on-equity number I have not verified. That test stays open, and I will come back to it when the filings are in front of me rather than a summary of them.

What this establishes

Two decisions, both large, both chosen rather than forced, both made by the same person.

An acquisition made in mid-2020, written down by $442.7 million after the company had itself disclosed the goodwill risk and its own limited experience in the area.

And $812.6 million spent on its own shares at an average price now more than three times the market.

Neither was a response to a crisis. Both were made from a position of strength, in years when the business was growing quickly and revenue was rising.

A record of growth and a record of allocation are different records, and this company has been graded almost entirely on the first one.

Tomorrow

What he said would happen, against what happened.

There is a specific public forecast attached to that acquisition, made at the time of purchase, and it can be checked against the outcome. Then the letter from the year the write-off landed, to see how the company described it in the document it wrote freely.

Not investment advice. The subscriber decides.

Start with why any of this matters before I get to the numbers.

The rule has to work in both directions

Yesterday I wrote that a long record can be luck riding a good industry, and that outcomes can be borrowed from a rising tide.

If I will not credit a management team for growth the whole sector enjoyed, I cannot blame one for a decline the whole sector is suffering. Same test, opposite direction. Without that check there is no argument I could make this week that could be proved wrong. Every poor number would count against management and every decent one would count for them, which is not analysis, it is decoration.

Two of six

The companies competing for this customer are Vuori, Alo Yoga, Athleta, Rhone, Gymshark and Nike.

Vuori, Alo Yoga, Rhone and Gymshark are all private. They file nothing. Everything published about their growth comes from the companies themselves, from funding announcements, or from trade estimates, and none of it is audited or filed. I have no way to check any of it, so none of it is in this piece.

That leaves Athleta and Nike.

Four of the six brands most often named as taking this customer cannot be examined at all. That is not a footnote. It shapes everything below.

The closest comparison reported the same number

Athleta is owned by Gap, which reports it as a brand within its results. Women’s activewear, sold mainly through American malls, to broadly the same customer.

For its quarter ended 1 August 2026, Gap reported Athleta net sales of $264 million, down 12%, with comparable sales down 12%.

Lululemon’s Americas comparable sales, for its quarter ended 2 August 2026, fell 12%.

Same category. Same market. Quarters ending one day apart. The same number.

I did not set out to find that and it complicates what I expected to write.

The consumer did not stop buying clothes

Inside Gap, in the same quarter, Gap brand comparable sales rose 10% and Banana Republic rose 3%. Old Navy fell 4%. The company’s overall comparable sales fell 1%.

One retailer, one quarter, the same malls and broadly the same shoppers. The denim brand grew double digits and the activewear brand fell 12%.

I want to be careful about what that proves, because I nearly claimed more than it does. Denim and activewear are not the same category. The research firm Circana, whose data the industry runs on, separates them: activewear on one side, non-active apparel including jeans on the other. So Gap brand growing tells you nothing directly about whether activewear is soft.

What it does establish is narrower and still useful. People were in the malls and they were spending. The consumer did not stop buying clothes. Whatever happened to Lululemon in the Americas, it did not happen because Americans stopped shopping for apparel.

The category itself is shifting

For the category, there is separate evidence, and it is a step further from the source than I would like.

Retail Dive, citing Circana’s Consumer Tracking Service, reported earlier this year that United States activewear apparel sales were up 2% against the prior year while non-active apparel was down 2%. Jeans, in the second group, grew 4%.

So activewear overall was still outrunning the rest of the wardrobe. Not collapsing.

But in the same reporting, a Circana apparel analyst, Kristen Classi-Zummo, described a clear shift away from leggings, sports bras and other performance products, even as activewear continued to outpace the apparel market.

That figure is from earlier in the year, not from the August quarter, and it comes through a publication rather than from the firm directly. I am giving it the weight that deserves, which is directional rather than precise.

Nike sits between the two. For its fiscal year ended 31 May 2026, Nike Brand apparel revenue rose 2% in constant currency, and North America apparel rose 4%. North America comparable store sales fell 2%, not 12%. But Nike apparel is a far wider basket than tights, and I am not presenting Nike as healthy either: the same filing shows Nike Direct down 6%, brand digital down 12%, Converse down 31% and net income down 3%.

Activewear did not stop working. The performance products at the centre of it appear to be where the softness sits, and that is most of what this company sells.

The explanation covers a sixth of the business

Yesterday I set out the geography without comment. Here is the comment, and I want to be careful with it because the numbers can be made to say more than they do.

China did slow. Comparable sales there fell 8%, and revenue fell 2% in constant dollars. It rose 4% only in reported dollars, which is a currency effect rather than a sales one. So her answer was addressing something real.

The question is how much of the problem it addresses.

China Mainland is roughly a sixth of this company’s revenue. The Americas is 67% of it, down from 70% a year ago, and Americas comparable sales fell 12%, four points worse than China.

And the filing gives that larger decline a different reason. It attributes the Americas fall to traffic, conversion and average order value, all moving the wrong way at once. Nothing in that sentence is about brand sentiment.

Brand noise in China is an answer about a sixth of the business. Two thirds of it fell harder, and the filing explains that part differently.

I should be fair about one thing. She was asked about China, and an executive answering the question put to her is not dodging. Analysts choose what to ask. But an explanation that covers the smaller part of a decline is still only an explanation of the smaller part, and a reader who heard the call and not the filing would come away with the wrong impression of where this company’s problem sits.

Athleta is a North American business. It fell 12% in the same quarter. Whatever is happening to Lululemon in the Americas is happening to the one comparable public company in the same market, and no event in Beijing accounts for either.

About that word

I have used her word twice now without examining it.

Noise describes weather. Something that happens around you, that you did not cause and cannot control, that passes. It also has the useful property of containing no claim, which means there is nothing in it to check.

There is a specific thing it may refer to. According to Forbes, on 30 May the company staged a yoga event on the Great Wall of China with the actor Zhu Yilong and roughly two thousand attendees, promoted as honouring Chinese culture. The performance featured a drum that critics identified as a Japanese taiko rather than a Chinese dagu. The criticism drew more than fifty million views on Weibo. Forbes reported that the company took over two weeks to acknowledge it and apologise, and that its statement said limitations in its professional knowledge had left it unable to identify potential controversies.

That event sits inside the quarter that ended on 2 August. I cannot tell you it caused anything, and one article I read quoted people expecting little short-term sales impact.

What I can say is that it was not noise. An event the company planned, staffed, promoted and then took two weeks to address is not something that happened to it. It is something it did.

The two-week gap is the part I will come back to on Thursday, because how long a company takes to say a thing went wrong is a decision, and decisions are what this week is about.

What this establishes

Less than a clean answer, and more than I expected.

It is not the consumer. Denim grew 10% in the same malls, in the same quarter, to the same shoppers.

It is not all of activewear either, which Circana had up 2% while the rest of the wardrobe fell.

It is not only this company. The one comparable public business selling women’s activewear in North America reported exactly the same 12% decline in the same quarter.

Something is wrong in the performance end of North American women’s activewear, and both of the public companies in that description have it.

That is as far as filings can take me, and the reason is the four private companies. If Vuori and Alo and Rhone and Gymshark are taking this customer, their filings would show it. There are no filings. The evidence that would separate a category problem from a share problem does not exist in public.

Which makes the rest of the week matter more, not less

If the sector had collapsed, there would be no management question worth asking.

If the sector had been fine, the decline would point straight at the people and the rest of the week would be a formality.

Neither happened. Part of this looks like something happening to a category. Part of it is happening in a market nobody at the company was asked about, with an explanation in the filing that has nothing to do with the answer given on the call.

So the only evidence that can separate those is what this company did with its own money, what it said about its own results, and what it took while saying it. That evidence is filed, it goes back a decade, and nobody has to guess at it.

Tomorrow

Eight years of Calvin McDonald’s capital record.

Ten years of cash flow statements opened at once. What they bought, what they wrote off, and which way the share count moved. There is one acquisition in there that the whole day turns on.

I will also run the first test I described last Monday, which is whether earnings grew faster than the capital base, because a business that adds to its equity every year produces rising earnings almost on its own, and that flatters a record that may not deserve it.

Not investment advice. The subscriber decides.

Let me be careful about what my own eyes are worth here.

Last week I described a method. This week I run it.

I ended last week on a line I want to pick up this morning. Every position is a bet on people, whether you admit it or not, so the size of the bet should match the evidence you have on them.

That is easy to say. Getting the evidence is the work, and it is the part nobody watches anybody do.

Over five days last week I set out where that evidence lives. Where the retained cash went. What price they paid for their own stock. Whether they named the bad year in the year it happened. What they took while writing it. And what to do when the record is too short to contain a bad year at all.

So this week I go and get it, on a real company, in public, and you watch what it produces.

The company is Lululemon, and the timing is what makes it worth six days. Most reviews of a management team look at people who are in the job. Here the chief executive of the last eight years left in January, two interim leaders have been running it since, and the incoming one starts tomorrow morning. There is no team in place to grade.

That sounds like a reason to wait. I think it is the reason to look now, because a company between leaders is the only time you can see the whole record laid out and nobody has yet started rewriting it.

A method nobody has seen run is a diagram. This is the same method with a company attached and the results printed whether they flatter it or not.

One promise before any of it. Where a test I published last week cannot be run here, or runs and tells me nothing, I will say so. A week that only demonstrates the tests that happen to work is an advertisement, and you would be right not to trust the next one.

What I saw is a reason to look, not a finding

One person, one mall, a handful of visits. That is an anecdote. It is not a sample, it does not represent the country, and I have no idea whether the shop I walked past is typical of the 825 company-operated stores the company reported in its quarterly filing on 3 September.

Philip Fisher had a name for this kind of observation, which I wrote about last Monday. Scuttlebutt. You learn about a business from the people around it rather than only from what the company publishes, and the point of it is not to replace the filings. It is to notice when the outside picture and the official one disagree, because the disagreement is the finding.

Here they appear to disagree, and I bought Dillard’s and Ralph Lauren off the same instinct years ago. Being a customer gave me a reason to look at both. It did not give me the answer. The filings gave me the answer.

So the question this week is not whether I saw a busy store. It is what a busy store and a 12% decline can both be true at the same time.

There is at least one answer that requires nothing surprising. Comparable sales measure what the same stores sold against the same period a year earlier. A shop can be full and still sell less than it did last year, if people are buying fewer items, or cheaper ones, or if last year was busier still. Traffic and spending are different measurements and only one of them is in the release.

That is a possible explanation, not a demonstrated one, and I am not going to pretend I have established it from a car park.

What the company reported on Thursday

These are the company’s own figures, from the quarterly report it filed with the Securities and Exchange Commission on 3 September and the call held the same day.

Net revenue fell 4%, or 5% in constant dollars, to $2.4 billion from $2.5 billion. Global comparable sales fell 9%, or 10% in constant dollars. In the Americas, comparable sales fell 12%. International comparable sales fell 3%, with revenue there up 4%.

Earnings per share came in at $2.92 against $3.10 a year earlier. That figure beat what analysts expected and it is lower than last year, which are both true at the same time and worth holding onto.

Then the numbers that moved the stock. The company cut its full-year outlook for the second consecutive quarter, to revenue of $10.35 to $10.5 billion, a decline of 5% to 7%, from a prior range of $11 to $11.15 billion. Full-year earnings per share guidance came down to $9.48 to $9.73 from $10.95 to $11.15. Third-quarter revenue is guided to fall 10% to 11%.

Operating margin was 18.8%, against 20.7% a year earlier. That figure includes $134.5 million of tariff refunds. Take them out and operating income is roughly $319 million on $2.42 billion of revenue, about 13.2%, which is more than seven points below last year.

The stock fell around 18% and traded under $100 for the first time since 2018.

Three more from the same disclosures, which matter more than they first appear.

Markdowns rose 70 basis points in the quarter, and the company expects them up again in the third quarter. A markdown is a price reduction, and a brand charging a premium for a logo does not usually need more of them.

The company ended the quarter with 825 company-operated stores, up from 811 at the start of the fiscal year and 784 a year earlier. It opened stores through a half in which sales at existing stores fell 9%.

And this, which is the line I keep returning to. The filing says the decline was driven mainly by reduced traffic, lower conversion, and lower average order value in the Americas.

Read that again slowly. Fewer people came in. Of the ones who came, fewer bought something. Of the ones who bought, they spent less than they used to.

Three separate things went wrong at the same time, at three separate points in the same transaction. That is not one problem. It is the whole funnel.

Nor is it confined to a channel or a country. Digital revenue fell 6%. United States revenue fell 8% and Canada fell 11%. Women’s revenue fell 4% and accessories fell 13%. China Mainland revenue rose 4% in reported dollars.

I am not going to tell you whether the price is attractive. I have not done that work and it is not what this week is about.

Why I am spending the week on management

Because a falling price raises a question that price cannot answer.

A brand this strong does not usually stop working overnight, and a business doing $10 billion of revenue with a 60% gross margin is not a broken machine. Something is wrong, and the range of possible somethings is wide: the product, the competition, the consumer, the pricing, the execution, or the people deciding all of it.

Management is one test among several. It is not the whole analysis and I would be misleading you to present it that way. But it is the test I spent last week building, and it happens to be the one that matters most when a company has to change direction, because changing direction is a decision and decisions are made by people.

There is one more reason, and it comes from the company itself. Asked on Thursday’s call about weakness in China, interim co-chief executive Meghan Frank attributed it to brand noise affecting sentiment and a softer Tmall shopping event, rather than to macro issues.

That is management saying this is not the industry and not the consumer. It is a claim about their own brand and their own execution, which is a claim I can test.

And this company has an unusual amount of management to look at.

Three records inside eight months

This is the thing to hold onto, and it is a habit worth applying to anything written about this company. When you read a claim about Lululemon’s management, check which of the three records it is describing, because they are separate and they answer different questions.

Calvin McDonald ran the company from 2018 until 31 January 2026. Revenue went from $2.6 billion to $10.6 billion under him. He left, and no filing I have seen explains why, which is a sentence I will come back to on Wednesday.

Meghan Frank and André Maestrini have run it as interim co-chief executives since. Thursday’s quarter is theirs. So is every decision made about capital in the last seven months.

Heidi O’Neill becomes chief executive tomorrow, 8 September. She spent more than twenty-five years at Nike, most recently as president of consumer, product and brand. She has run this company for zero days.

Three people, three records, and they answer different questions. Grading O’Neill on the last eight years is a category error. Grading the company on her Nike years is the opposite one. And the interim period is a real record in its own right. It contains the most recent decisions anyone has made with this company’s money, and it is the one I have seen least written about.

Last Monday I wrote that a projection is a claim about people who have not yet done the thing, and a record is a claim about people who already did. Two of these three have records. One does not, yet.

Tomorrow

Whether this is a Lululemon problem or an industry problem.

Last Monday I wrote that a long record can be luck riding a good industry, and that outcomes can be borrowed from a rising tide. That rule has to work in both directions. A bad record can be a bad industry, and if I skip that check, everything I write for the rest of the week is unfalsifiable.

So before I grade anybody, I put this company against its sector, using competitors’ own filings. The rest of the week is in the card above, and I will use notes throughout for figures that would otherwise pack the articles.

What this week is not

It is not a valuation. I have not done that work and I will not blend it into this one, because a low price has a way of making a management team look better than the evidence supports, and I would rather run the two separately and see whether they agree.

It is not a recommendation, and it will not become one by Friday.

And it is not a verdict on a brand. I saw a busy store. That observation survives everything I am about to write, and so does the 12% decline.

A great brand and a capable management team are different things, and a company can have one without the other in either direction.

Not investment advice. The subscriber decides.

Four days of tests, and each one needed a decade of decisions to run on. Plenty of companies have not existed that long, and the ones I find most interesting are often the youngest ones. Treating that as a closed question would be a lie about what I do, because I keep looking at them.

Start with what does not disqualify someone, because this is where the thinking usually goes wrong.

The wrong test is the industry

The soap salesman was Tom Murphy, a product manager at Lever Brothers, and the job came through a friend of his father’s. He took it with no broadcasting experience of any kind.

Seven years later he needed someone to run operations and hired a man from the new products division at General Foods, who had been testing Jell-O on his wife to work out what would sell, and who had never set foot inside a television station.

Murphy and Dan Burke went on to build Capital Cities and to buy ABC, a company several times their size, for $3.5 billion.

Here is the part that matters for our purposes. By William Thorndike’s accounting in The Outsiders, one dollar invested when Murphy became chief executive in 1966 was worth $204 by the time he sold to Disney in 1996. That is a 19.9% annual return against 10.1% for the S&P 500.

And against 13.2% for an index of leading media companies.

That second comparison is the one to hold. On Monday I warned that a long record can be luck riding a good industry, and that outcomes can be borrowed from a rising tide. Broadcasting was a rising tide. Murphy beat the tide by more than six points a year for three decades, which is the version of the evidence that survives my own objection.

A man with no experience in the business outperformed the people who had spent their lives in it. Whatever he lacked, it was not the thing that mattered.

So new to the sector cannot be the disqualifier. If it were, it would have caught the chapter that opens Thorndike’s book.

The right test is whether they have ever decided anything

The disqualification is not the wrong industry. It is the absence of any record of deciding.

You would not hire a head coach who has never coached. Not because he came from another sport, but because nobody has ever watched him choose a play with the game on the line.

Being excellent at the thing is not evidence of being good at deciding where the money goes. A founder whose entire record is technical achievement has demonstrated the first and nothing about the second.

So three questions, none of them about their sector.

Have they ever had to say no to growth that was available to them. Have they run anything through a contraction rather than an expansion. Have they built something and lived with the consequences of their own decisions rather than inheriting someone else’s.

What does not count is the resume. A resume is a list of rooms someone was in.

Murphy and Burke were explicit about this and applied it as employers rather than only as a philosophy. Thorndike records that both men preferred intelligence, ability and drive over direct industry experience, having had the benefit of that judgment themselves. Bill James was thirty-five with no radio experience when he was handed WJR. Phil Meek came from Ford at thirty-two with no publishing background to run a newspaper. Bob Iger was thirty-seven and had spent his career in broadcast sports when he was given ABC Entertainment.

They were not gambling on inexperience. They were declining to treat industry tenure as the qualification.

The exception, and why it is real

There is a version where I back an unproven team anyway, and it rests on something Buffett wrote in 1980.

He observed that with few exceptions, when a manager with a reputation for brilliance takes on a business with a reputation for poor fundamental economics, it is the reputation of the business that stays intact.

That line gets quoted as a warning, and it is one. Read the other direction it is a permission slip. If the economics of a business dominate the quality of the people running it, then an extraordinary business asks less of its managers than a mediocre one does. The moat does work the manager would otherwise have to do.

That is the honest basis for buying a wonderful business with an unproven team. It is the same asymmetry Buffett spent decades exploiting, pointed at a different variable.

It has two limits, and the limits are where I think the current enthusiasm is thin.

Limit one is the price

Margin of safety is the gap between what you pay and what a business is conservatively worth. In practice that gap is your budget for being wrong.

Management error is one of the things the budget pays for. Buy at a real discount and the team can make an expensive mistake while you still do acceptably. Buy at a price that already assumes everything goes right and there is no budget left, so the first bad allocation decision comes straight out of your return.

Margin of safety is what pays for management mistakes. At a price that requires perfection you are not buying a business, you are underwriting people you have never met.

So price does not only set the return. It sets how much management record you need before acting at all.

Limit two is how much cash the business must spend

This is the limit that gets skipped.

The 1980 logic works cleanly for a business that produces cash and needs little reinvestment to hold its position. There, allocation happens at the edges and the moat does the compounding.

A business that must deploy an enormous amount of capital every year is a different animal. Allocation is not a side activity a strong moat absorbs. It is the main event, and the company you own in ten years is close to the sum of what management chose to build.

You cannot route around a manager whose principal job is spending.

Which is why the two dials belong together. Cheap enough, and undemanding enough of capital, and the business can carry a team you cannot check. Priced for perfection and consuming capital at scale, and the team is the investment, whatever the product happens to be.

I am not reprinting the technology capital spending figures I gave you on Monday. They came forward from an earlier series and I have not re-sourced them this week, which under my own standard means they do not go in again. Look them up in current filings for whichever company you are weighing, and place it on the second dial yourself. The structure is the point, and the structure is checkable.

Every management team has a hidden assumption

I built the Firewall to name the single hidden assumption a stock price depends on. Not the ten things that could go wrong. The one thing that, if false, breaks the case.

It took me until this week to see that management teams have one too.

To be running a large public company there has to be a story. Not a marketing story, a story the team tells itself about why it is the right group for this problem at this size. Underneath it sits one assumption carrying the load.

For a founder whose company grew into something enormous, it is often that the hard part was the invention and the capital deployment is a detail. For an operator brought in from a mature industry, it is the discipline that travels. For a team in a capital-hungry business, it is frequently that money will keep being available on the terms they have grown used to.

Name it, and you can treat it the way we treat a price assumption. Set the confirm line and the break line before the news arrives, so you are reading evidence rather than reacting to it.

The question is not whether management is good. It is what would have to be true about these people for this to work, and what you would see if it stopped being true.

The one that started this

I graded Nebius, found a business growing around 454% a year, and could not buy it. I said the price was the reason.

Working through this week, I think the price was half my reason and it was the half I could articulate at the time. The other half is that at a price demanding perfection I needed a management record long enough to believe perfection was achievable, and I did not have one to read.

That is a statement about what I can verify, not a criticism of anyone running that company. I could be wrong about it. The point of writing the standard down now is that next time the reasoning is on paper before the decision instead of after.

The scorecard

Five days, five questions, and they run on any company in an afternoon.

Where the retained cash went, from ten years of the cash flow statement. What price they paid for their own stock, from the repurchase dollars against the change in share count. Whether they named the bad year, from the letter for the year the numbers already told you was bad. What they took while writing it, from the proxy. And when there is no record at all, what the business and the price have to be before you accept that.

Underneath all five is the thing I said on Monday and came back to on Thursday. I am not looking for brilliance. I am looking for people who know what they are not, and who did something about it that cost them.

Run it this weekend on a business you already own. Not one you are considering. One you own.

Two tracks

The short list has always had two columns on it. Quality, and price. This week was about the third one, and it is the column that decides whether the first two survive contact with the people in charge.

When the evidence runs out, and it will, the rule I am left with is short enough to say in one line. Every position is a bet on people whether you admit it or not, so size the bet to the evidence you have on them rather than to how much you like the idea.

You know how I end these. Hunting new ones, and waiting to buy more of the ones I already hold when fear puts them on sale. Same two tracks as always. The difference is that a week ago I could only grade one half of what I was buying.

Not investment advice. The subscriber decides.

There are two kinds of document in a company’s file, and the difference between them is the reason this piece exists.

The financial statements are a record. They are governed by accounting standards, audited by someone paid to disagree, and largely not a matter of choice. When a company overpays for an acquisition, the goodwill write-down appears whether anyone wants it to or not.

The letter to shareholders and the proxy statement are self-report. Nobody is required to be interesting, specific, or forthcoming in either. They are the company describing itself, and description is where a management team has the most freedom and therefore reveals the most.

Three days of this week have been spent on what a team did. Today is about what they say they did, and the gap between the two is not a rounding error. It is the finding.

Sixteen

The cleanest version of this comes from Buffett auditing his own vocabulary.

In his 2024 letter to Berkshire shareholders, he reported that across the 2019 to 2023 period he had used the words mistake or error sixteen times in his letters, and added that many other large companies had not used either word once over the same five years.

He named a single exception. Amazon’s 2021 letter, which he credited with some hard observations about itself. The general run of corporate communication to owners he described as pleasant talk and photographs.

Then the detail that gives the count its weight. He wrote that he had served as a director of large public companies where mistake and wrong were effectively forbidden words at board meetings and on analyst calls, and that the implied claim of managerial perfection made him uneasy.

His own qualification stays attached, because he included it. There are circumstances where legal exposure makes limited discussion the sensible course. This is a litigious country and that is a real constraint.

Buffett credited Munger with the harder half. Munger’s position was that the sin is not the mistake, it is delaying the correction of it, which he called thumb-sucking. Problems cannot be wished away and they require action, however uncomfortable that is.

Which tells you what the count is measuring. Naming an error in writing is the cheap part. It matters because a team unwilling to say the word in a letter, where saying it costs nothing but discomfort, is not likely to be the team that moves fast when the same problem shows up in the business, where acting costs real money.

The count is useless without a denominator

Here is where I have to be careful, because a raw number tells you nothing.

Sixteen is meaningful for Berkshire because Buffett published it about himself over a defined period. You cannot take that figure to another company and grade against it. A team with three admissions in five years is not automatically worse than one with eight, and a company with zero might have had an uneventful five years.

The denominator you need is not a benchmark from outside. It is the work you already did.

You have ten years of cash flow statements from Tuesday. You know what they bought, what they later wrote off, and which way the count moved. You have the average price paid for their own stock from Wednesday. Somewhere in that decade there is at least one year where the numbers went badly, and you know which year it was, from a document the company did not get to write freely.

So the test is not how many times they used the word. It is whether they used it about the thing you already found.

Pull the letter for that specific year. Three outcomes, and they are easy to tell apart.

They named it, described what went wrong, and said what they were doing about it. They mentioned it in language so general it could have described any year at any company. Or the year that produced a write-down was characterised as a period of investment, discipline, or repositioning, and the write-down does not appear.

A team that admits a mistake you had not found is candid. A team that admits the one you were always going to find is doing arithmetic of a different kind.

That last distinction is worth holding. Timing is part of the test. An error named in the year it happened is a different signal from the same error acknowledged three years later, once the market has priced it and the admission costs nothing.

What the research supports, and what it does not

There is data pointing the same direction, and I want to state it at exactly the weight it can carry.

Feng Li, in the Journal of Accounting and Economics in 2008, found a statistically significant relationship between annual report readability and company performance. Firms with lower earnings produced reports that were harder to read, and firms whose reports were more readable had more persistent earnings. Researchers in the field call the pattern obfuscation.

The measurement has been challenged. Loughran and McDonald argued in 2014 that the Fog Index used in much of that work scores ordinary financial vocabulary as complexity, which makes it a poor instrument for business text.

So the direction has held up under other measures and the instrument is disputed. That supports a modest claim rather than a sweeping one. How a company writes about a bad year is not noise, and it is not proof.

Two smaller tells, both free

The headline metric. Every company chooses which number to lead with, and Buffett has been blunt about his own choice, dismissing EBITDA as a flawed favorite of Wall Street and reporting operating earnings instead. The tell is not which measure a company picks. It is whether the pick moves. A team that has led with the same number for a decade through good years and bad is reporting. A team whose headline figure migrates to whatever looked best that year is presenting.

The outside account. Monday I introduced Fisher’s scuttlebutt. Here is where it earns its place, because the letter is the company’s version of the year and customers, suppliers, competitors, trade press and job postings are versions written by people with no reason to improve it. Where the two agree you have learned little. Where they diverge, the direction of the divergence tells you which one was managing an impression.

What they took while they were writing it

The proxy statement is the second self-report, and it is the one with numbers in it.

In the United States it is filed as a form called the DEF 14A, ahead of the annual shareholder meeting. It sets out executive compensation in detail, the terms attached, and what shareholders are voting on. It is written by the company about the company, which puts it on the same side of the line as the letter.

Four things in it are worth ten minutes. Severance multiples and change-of-control provisions, meaning what an executive receives if the business is sold or they leave. Whether equity vests on a single trigger, releasing on the sale alone, rather than a double trigger requiring both the sale and a qualifying departure. Share pledging, where executives borrow personally against company stock, which quietly converts an owner into someone who needs the price to stay up. And how much of the package depends on results that already happened rather than on remaining employed.

Shareholders have been voting on some of this and the votes have moved. According to the Harvard Law School Forum on Corporate Governance’s review of the 2026 proxy season, average support for advisory votes on change-in-control pay fell from roughly 86% in 2024 to about 74% this year, with a record ten of those votes failing.

Then read the two self-reports against each other, because they cover the same twelve months and they can disagree. A letter naming a decision that went wrong, filed alongside a proxy showing the full package paid as though nothing did, is two accounts of one year. So is the reverse.

Why this is the day the week has been pointing at

Monday I said the trait I look for is narrower than intelligence. Whether a person knows what they are not good at, and acted on that knowledge when bluffing would have been easier. I said it was the thread running through every test in this series, and then I spent three days on arithmetic without coming back to it.

Here is why it had to wait.

Self-awareness does not appear in a cash flow statement. It cannot. A write-down records that a company paid too much; it says nothing about whether anyone involved understood why. The share count records that a repurchase happened; it does not record whether the team knew what the shares were worth when they bought them.

The trait only becomes visible at the moment a management team is free to describe itself and chooses to describe itself accurately. That moment is the letter. It is the one document where the cost of honesty is entirely borne by the person writing it, and where the reward for the alternative is immediate.

Every other test this week measures a decision. This one measures whether they can see the decision clearly, which is the thing that predicts the next one.

What this still cannot tell you

Everything so far has assumed a record exists.

A decade of financing lines to total. Enough share counts to see a direction. A shelf of annual letters long enough to compare one against another. A proxy with years behind it rather than a single filing.

Some of the businesses I most want to own have none of that. The company is young, the team is new, and there is no decade to read. That is not a hypothetical and it is where the framework this week has built either holds or breaks.

Tomorrow, the exception.

Not investment advice. The subscriber decides.

Start with the standard, because it is stricter than it first appears.

Two conditions, and one of them is not enough

In his 2011 letter to Berkshire shareholders, Buffett set out when he favours repurchases. Two conditions, and he wanted both.

First, the company has ample funds for the operating and liquidity needs of the business. Second, the stock is selling at a material discount to intrinsic business value, conservatively calculated.

Intrinsic value, in plain language, is what the business is worth based on the cash it can produce over its life, as opposed to what the market happens to be charging for it today. Buffett’s word “conservatively” is doing real work in that sentence. A management team that wants a repurchase can always find a valuation that justifies one.

Notice what the second condition does. It makes the buyback a price decision rather than a policy. He put this plainly in his 2023 letter, writing that all repurchases should be price-dependent, and that what is sensible at a discount to business value becomes foolish at a premium.

A buyback is not a way of returning cash. It is management buying one particular stock, and the only stock they are allowed to buy is their own.

He also named who gains when a company overpays. The shareholders who sold, and the banker who recommended it. The owners who stayed are the ones who paid.

The number the announcement never gives you

Here is where I go past yesterday.

Tuesday I told you to track the share count rather than the buyback dollars. That is the beginning of the test, not the test. The count tells you whether the buyback did anything. It does not tell you whether it was done well.

For that you need the price they paid, and you can compute it yourself from figures the company already publishes.

Take the total dollars spent on repurchases over a period. Divide by the number of shares the count fell by over that same period. That gives you the average price management paid per share retired. Now set that number against the stock’s trading range across those years.

If the average sits in the lower part of the range, this is a team that bought when the market was unenthusiastic. If it sits in the upper part, they bought alongside everyone else, at the prices everyone else was paying.

One caution on the arithmetic. If the company issued shares over the same period, and most do through compensation, the count fell by less than the number repurchased. Your computed average price will be too high. Use the repurchase share figure from the cash flow statement or the equity note when it is disclosed, and treat the divided number as an estimate rather than a measurement.

That caution is also the finding. A company can spend an enormous sum on repurchases and end the decade with the same share count it started with. The dollars went out. Your ownership stake did not move. What was purchased was not your position in the business. It was the offsetting of shares issued to employees.

That is a real and common structure, and it is not hidden. It is visible to anyone who puts the dollars and the count side by side.

What the evidence says about how this goes

I want to be careful here, because this is a point where confident assertions outrun the data.

Researchers at the University of Kentucky examined 5,498 firms that repurchased stock in at least one quarter between 1984 and 2010, in a paper titled “Wiser to Wait: Do Firms Optimally Execute Share Repurchases?” They found strong evidence that share prices were higher, and valuation ratios less attractive, during the quarters when firms were repurchasing than during the quarters when they were not. Their summary was that firms on average buy when they should not.

McKinsey’s own work, published through the Harvard Law School Forum on Corporate Governance, reached a similar conclusion on timing. A majority of the companies they observed bought back shares when prices were high rather than low.

Now the part that complicates it, which I am including because leaving it out would be dishonest. That same McKinsey work found no compelling evidence that share buybacks damaged long-term value creation for investors overall. So the timing finding is robust and the consequence is contested. Poor timing on repurchases is not the same thing as a company being destroyed by them.

There is also a mechanical reason for the pattern that has nothing to do with anyone being foolish. Companies tend to have the most spare cash when business is good, and business tends to be good when share prices are high. The behaviour follows the cash. According to data from S&P Capital IQ reported by CFO magazine, during 2009, with the S&P 500 below 700, only 53 buybacks of $300 million or more were announced.

Buffett has made the sharper version of this charge himself. He has written that American chief executives have an embarrassing record of committing more company money to repurchases when prices have risen than when they have fallen. That is his assessment, and I am attributing it to him rather than adopting it as a measured fact.

What it looks like when someone does it properly

Henry Singleton ran Teledyne, and I mentioned him on Monday only as one of Thorndike’s eight. The record itself deserves its own space.

Through the 1960s Singleton used Teledyne’s expensively priced stock as currency, acquiring roughly 130 companies while the shares traded at high multiples of earnings. Then the market turned, the multiple collapsed, and he reversed direction.

Between 1972 and 1984, across eight separate tender offers, Teledyne repurchased approximately 90% of its outstanding shares, spending on the order of $2.5 billion. Shares outstanding fell from 88,827,372 in 1971 to 22,564,756 by 1980. Earnings per share rose roughly fortyfold between 1971 and 1984.

Read those two phases together, because separately they mean less. He issued stock when it was expensive and bought it back when it was cheap. That is the same discipline applied twice, in opposite directions, which is harder than it sounds and rarer than it should be.

One detail I am including because it cuts against the clean version of the story. The final tender, in 1984, was priced at $200 a share, roughly $30 above the market at the time. Singleton was not mechanically a low-price buyer at every moment across twelve years. The record is excellent. It is not spotless, and a story that has no rough edges usually has had them removed.

He was not right about the price every time. He was thinking about the price every time. That is the part you can check.

The 2026 version

Monday I gave you the buyback figure for the first four months of this year, reported by Bloomberg citing Birinyi Associates as the largest start to any year on record. I gave it without comment because the frame was not built yet. It is now.

A record dollar total tells you about volume. It tells you nothing about price, and price is the entire question. The same headline is consistent with a market full of disciplined allocators buying value, and with a market full of teams buying alongside each other near highs. The number does not distinguish between them.

What distinguishes them is available per company, for free, and it is arithmetic rather than opinion. Dollars spent. Change in share count. Average price paid. Trading range over the same period.

The afternoon, part two

Take the same company you used yesterday.

Find the repurchase line in the financing section of the cash flow statement for each of the last ten years. Find the share count on the cover of each annual report. Compute the average price paid. Put it next to what the stock did in those years.

You will end up with a single number that tells you whether this team treats their own shares as an investment or as a policy.

What this still cannot tell you

The arithmetic gives you the decision. It does not give you their account of the decision.

A team that overpaid and then said so in the next annual letter is a different proposition from a team that overpaid and described the year as a success. The numbers are identical. The management is not.

Tomorrow I leave the financial statements and go to what they wrote, and to the document that records what they took while they were writing it.

Not investment advice. The subscriber decides.

Yesterday I gave you the figure from Buffett’s 1987 letter without showing the work: ten years in, at an ordinary retention rate, one chief executive has deployed more than 60% of the capital in the business.

I should have shown the work. It is arithmetic and it takes one line.

If a company retains 10% of net worth a year, the capital base grows by a factor of 1.1 each year. After ten years it is roughly 2.6 times its starting size, which means the original base is down to about 39% of the total and everything else arrived on this person’s watch. The share is one minus 1.1 to the power of negative ten, or 61.45%. At year five it is already 37.9%.

The number is not a rhetorical flourish. It is a division problem, and you can run it on any retention rate you like.

That is the reason I now open the cash flow statement before the income statement.

The part of that letter I skipped

There is a line in the same letter I let stand yesterday without the qualification it needs.

Buffett’s warning about chief executives who go looking for help with allocation, from staff, from consultants, from bankers, is not an argument against seeking expertise. Read that way it becomes an excuse for exactly the behavior this week is trying to catch, which is a manager bluffing through something they do not understand.

The warning is narrower and better than that. The allocation judgment itself cannot be handed to someone whose incentives differ from the owners’. An investment bank is paid when a transaction happens, so it is structurally in favor of a transaction. That is a fact about the arrangement rather than an accusation about anyone inside it.

Buffett also gave the problem its sharpest image, comparing a manager promoted into capital allocation to a gifted musician whose final promotion is not a performance at Carnegie Hall but the chairmanship of the Federal Reserve.

Hire past your weakness, keep the decision. Those two things together are the test, and either one alone fails it.

Five doors

Every dollar a company keeps goes through one of five doors.

It gets reinvested in the existing business. It buys another company. It pays down debt. It goes out as a dividend. Or it buys back the company’s own stock.

That is the entire menu. Management picks, every quarter, forever.

Grading the picks does not require a model. It requires reading ten years of the cash flow statement in one sitting, which takes an afternoon.

It is worth knowing how uncommon that is, and I would rather give you a number than an impression. Tim Loughran and Bill McDonald, writing in the Journal of Behavioral Finance, used the SEC’s own EDGAR server logs covering 2003 to 2012 to count how often investors requested company filings. The average publicly traded firm had its annual report requested 28.4 times in the period immediately after filing.

Not 28,400. Twenty-eight.

Two limits on that figure, because it should not be stretched further than it goes. It counts direct requests to EDGAR, so it misses anyone reading the same document through a broker, a terminal, or a data provider. And the sample ends in 2012. What it does establish is that first-source filings were being pulled far less than the volume of commentary about those companies would suggest.

Here is what I look for.

Total the acquisitions over the decade and compare that total to what the acquired businesses are contributing now. If a company spent $4 billion buying things and the segment those things live in has not grown, that is an answer. Look for goodwill write-downs, which are the accounting admission that a company paid more for something than it turned out to be worth. A decade with several is a decade of overpaying.

Compare capital spending to depreciation. When a company consistently spends far more on plant and equipment than it is writing off, it is either growing hard or running to stand still, and the two look identical in the cash flow statement until you ask which.

Track the share count. Not the buyback dollars, the count. Dollars spent tell you what they did. The count tells you whether it worked.

The number that separates growth from running in place

This is where Buffett gave us a tool, in an appendix to his 1986 letter, and it is the one I use most.

He called it owner earnings. Take reported earnings, add back depreciation, amortization, and other charges that did not involve cash going out the door, then subtract the capital spending the business needs simply to hold its competitive position and its unit volume. That last piece is maintenance capital expenditure, meaning the money spent to keep what you already have rather than to build something new.

What is left is roughly what an owner could take out of the business in a year without weakening it.

The distinction matters because the common measure, free cash flow, subtracts all capital spending and therefore treats a dollar of growth investment the same as a dollar spent replacing a worn-out roof. Those are not the same dollar. One is optional and should be judged on its expected return. The other is a cost of staying in business.

Buffett was direct about why he bothered. Owner earnings, not the reported figures, are the relevant number for valuation, both for investors buying stocks and for managers buying whole businesses.

The catch is that companies do not report the split. Estimating how much of capital spending is maintenance and how much is growth is a judgment call, and two careful people will land in different places. That is a feature rather than a bug. The exercise forces you to ask where the returns are coming from, using a split the company did not choose for you.

A business that must spend heavily every year just to stay where it is has less to give you than its earnings suggest. That gap is not reported. You have to compute it.

The tests travel. The documents change.

Everything I have described so far assumes a particular kind of company. One that generates cash, keeps some of it, and spends it on things you can point at. That describes a lot of businesses. It does not describe all of them.

I want to be direct about this, because a method that only works on Berkshire-shaped companies is not a method. It is a preference.

The five questions generalize completely. Where did the capital go, what return did it earn, how much of the spending was just standing still, what price did they pay for their own stock, and is there a quick way out. Those hold for any company anywhere. What changes is which document answers them.

For a company that has never retained a dollar, the whole thing inverts. There is no retained cash to trace, so the allocation record is what they raised and what they surrendered to raise it. The share count going up is the document, not the share count coming down. Dilution history is the cash flow statement of a business that has not started generating cash yet.

For a business whose main investment is people rather than plant, the spending runs through the income statement as research and sales rather than appearing as capital expenditure. The maintenance-versus-growth question is still exactly right. You will not find the answer in the cash flow statement, because there is nothing to find there.

And the return-on-equity test needs a correction that Buffett’s own framing can obscure. Penalizing a company for growing its equity base is correct for a mature business and wrong for one earning high returns on every incremental dollar, where retaining everything is the right decision. The general form of the question is the return on new capital, not the level of return on all capital.

One more, for anyone holding something listed outside the United States. There is no proxy statement to read. Barclays, to take one I own, discloses the equivalent in a UK remuneration report. Different document, same question.

The instrument is not the test. If you cannot find the filing, that does not mean the question stopped applying.

Why decent, intelligent people spend money badly

None of this explains why capital gets misallocated so consistently. Bad managers would explain a few cases. It would not explain the pattern.

Buffett’s answer came in his 1989 letter, in the section reviewing his first twenty-five years of mistakes, and he called it his most surprising discovery. He named it the institutional imperative.

His starting assumption had been that decent, intelligent, experienced managers would make rational business decisions more or less automatically. He learned that this is not so, and that rationality tends to wilt when the imperative comes into play.

He described four mechanics. An institution resists any change in its current direction, the way an object in motion resists a change in course. Projects and acquisitions materialize to absorb whatever funds happen to be available. Any wish of the leader, however poorly founded, gets supported by detailed rate-of-return studies prepared by the people who work for that leader. And the behavior of peer companies, whether in expanding, acquiring, or setting pay, gets copied with little thought.

Then the line that makes it useful rather than cynical. These are institutional dynamics, not venality or stupidity.

That distinction is why I can write about this without picking a side about anyone. Nobody in this description is a villain. The mechanism runs on ordinary incentives inside ordinary organizations, and it runs hardest when there is a lot of money around and everyone in the industry is moving the same direction at once.

Buffett’s response was structural rather than moral. He wrote that after some expensive mistakes he tried to organize and manage Berkshire in ways that minimized the imperative’s influence, and to concentrate investments in companies that seemed alert to the problem.

That last clause is a management test in five words. Does this team seem alert to the problem.

What that means to look at right now

I will describe the mechanics and leave the conclusions to you.

Yesterday I put two numbers in front of you without comment, the capital spending guidance across the largest technology companies and the record start to a year for buyback announcements. Here is the comment.

Hold those numbers against the second and fourth mechanics. Projects materialize to absorb available funds. Peer behavior gets copied.

I am not saying the spending is wrong. I have no idea, and neither does anyone writing confidently about it. I am saying that this is the exact set of conditions under which the imperative operates most strongly, and that the question worth asking about any individual company in it is narrow and answerable: does this particular management team behave like a group that is alert to the problem, or like a group that is matching its peers.

The difference shows up in what they say no to. A team that has declined something available to it, publicly, and explained why, has told you which one it is.

The afternoon

Pick a company you own. Not one you are considering, one you own.

Open ten years of cash flow statements. Total the acquisitions. Find the write-downs. Compare capital spending to depreciation. Track the share count, not the dollars.

You will finish with a view of that management team built from what they did rather than what they said, and you will have it before the price moves rather than during.

The short list I keep is supposed to be businesses I could act on quickly. For years that list was built on quality and price. This is the column I never filled in.

There is one thing this afternoon cannot tell you, and I want to name it rather than let you find out later.

Everything above reveals what management did. Totals, write-downs, the direction of the share count. None of it reveals whether they got a good deal. A company that spent $4 billion on acquisitions and a company that retired 8% of its shares both show up as activity, and activity is not the same as judgment. The price they paid is a separate question, and it is the one that separates a disciplined allocator from a busy one.

Tomorrow I take the fifth door on its own, because it is the only one of the five where the price is visible to you in advance.

Not investment advice. The subscriber decides.

Andrew Kilpatrick spent three decades recording what Buffett and Charlie Munger said at Berkshire annual meetings. In his account, Buffett reduced the evaluation of a management team to two things: how well do they run the business, and how well do they treat the owners.

That is the whole frame. Every other test I will write about this week is a detail hanging off one of those two hooks.

But there is a rule that sits above both questions, and I want to put it first because it decides what evidence you are allowed to use.

Buffett printed the rule in the back of the annual report

Since at least 1983, Berkshire’s annual report has carried a short list of acquisition criteria on the page after the shareholder letter. Six items. Two of them are about people, and both say the same thing.

The second criterion asks for demonstrated consistent earning power, and then adds a clause most readers skim past: future projections are of no interest, and neither are turnaround situations. The fourth criterion is four words long. Management in place. The parenthesis after it explains why: he cannot supply it.

Read those two together and you have a policy, not a preference. Buffett is not saying he prefers a proven team. He is saying that a plan is not admissible evidence, and that he will not underwrite someone’s potential with his own money.

A projection is a claim about people who have not yet done the thing. A ten-year record is a claim about people who already did it, repeatedly, through conditions nobody chose.

I want to be careful not to overstate what a record proves. A long record can be luck riding a good industry. That is why the record has to be read as decisions, not outcomes. What did they do with the cash in the fat years. What did they do in the year the business got hit. Did they buy their own stock when it was cheap or when it was expensive. Outcomes can be borrowed from a rising tide. Decisions cannot.

William Thorndike made this measurable in his book The Outsiders. He studied eight chief executives, including Henry Singleton at Teledyne and Tom Murphy at Capital Cities, and found their companies returned an average of 20.1% a year to shareholders during their tenures against 12% for the S&P 500 over the same windows. Compounded, that gap meant beating the index by roughly twentyfold.

None of the eight is remembered for charisma. What they shared was a long, visible, boring record of deciding where the money went.

There is one more thing worth naming before the week starts, because it is what I am looking for underneath all of this.

A record of decisions is evidence of something narrower than intelligence. It is evidence of whether a person knows what they are not good at, and whether they acted on that knowledge when it would have been easier to bluff. That trait is the one I trust, and it is the thread running through every test in this series.

Where the cash went tells you whether they knew the limits of what they could build. What they paid for their own stock tells you whether they knew the limits of their own optimism. Whether they name a mistake before the market finds it tells you whether they can see themselves clearly at all.

I am not looking for brilliance. I am looking for people who know what they are not, and who have done something about it that cost them.

That last clause is the whole guardrail. A chief executive who sounds humble on a conference call is performing humility, and performance is free. I want it in the form of a decision that gave something up.

The first question is not about charisma

Most coverage of a chief executive is coverage of a personality. The stage presence. The vision. The interview where they seem impressive.

None of that is the first question.

The first question is a number, and Buffett named the number as far back as his 1977 letter to Berkshire shareholders. He pointed out there that companies love to announce record earnings per share, and that a record is close to meaningless on its own. A business that adds to its equity base every year will produce rising earnings almost automatically, the same way a dormant savings account produces rising interest through compounding.

His preferred measure was return on equity capital. Return on equity, or ROE, is simply the profit a company earns each year divided by the money the owners have left in the business. It answers a plain question: for every dollar of mine you are sitting on, how many cents did you make this year.

A record earnings number tells you the company got bigger. Return on equity tells you whether it got better.

That distinction is the entire first question. A management team that grows earnings by 5% while the equity base grows 10% has not run the business well. It has run a larger version of the business worse, and the headline hid it.

The second question is the one almost nobody asks

How well do they treat the owners.

This is not about dividends, and it is not about whether the chief executive seems likable on an earnings call. It is about four concrete behaviors, and I will spend the rest of the week on them.

Do they allocate capital well, meaning do they put the retained profit somewhere that earns a decent return. Do they buy back stock at a price that helps me, or at a price that helps the optics. Do they tell me the truth early when something breaks. And do they take a share of the company for themselves through compensation that I would not have agreed to if anyone had asked me.

Those four are testable from public documents. Not one of them requires access, a conference, or a call with investor relations. They are in the annual letter, the cash flow statement, and the proxy statement.

Why I care about this now, specifically

I did not pick this topic because it is timeless. I picked it because 2026 is, as far as I can tell, the largest capital allocation moment any of us will watch in our investing lives.

Two numbers, both from the reporting I have already cited in this series and in the financial press. The Big Five technology companies are guiding to somewhere in the range of $775 to $800 billion of capital spending this year, most of it flowing to a narrow set of recipients. And according to Bloomberg, citing data from Birinyi Associates, American companies announced $665 billion of share repurchases in the first four months of the year, the largest start to any year on record.

Set aside every opinion about whether that spending is wise. The mechanical fact is enough: an extraordinary amount of shareholder money is being deployed right now by people who will not be asked to justify it for years.

Capital allocation is not a boring corner of governance. In 2026 it is the loudest thing happening, and almost nobody is scoring it.

The job nobody interviews for

Buffett made the sharpest version of this point in his 1987 letter, and it has stayed with me since I first read it.

His observation was that most people reach the top of a company by excelling at something else. Marketing. Production. Engineering. Administration. Sometimes internal politics. Then, on the day they become chief executive, they inherit a job they have likely never done and that is not easy to master, which is deciding where the company’s money goes.

He put a number on how much that job matters. A chief executive whose company retains earnings equal to 10% of net worth each year will, after ten years on the job, have been responsible for deploying more than 60% of all the capital at work in that business.

Read that again slowly. After a decade, the majority of the company you own was assembled by that person’s allocation decisions, not by the founder, not by the brand, not by the moat. By their choices about where the cash went.

Buffett added the part that stings. Chief executives who recognize they lack the skill often turn to their staff, to consultants, or to investment bankers. In his and Munger’s experience, that help tended to make the problem worse rather than better.

What my own record taught me

I own Dillard’s at an average cost of $33.43. It trades around $560 today. I own Ralph Lauren at $73.17, now around $378. Those are the two I point to most, and I want to be careful about why.

They are not evidence that I predicted anything. They are evidence that I was ready when fear put businesses I understood on sale, and that I did the work before the moment arrived rather than during it. The reward was for being ready, not for guessing.

But here is the piece I did not appreciate at the time. I bought a retailer and an apparel brand in a market that had decided both were structurally finished. The reason both worked was not that the market was wrong about the sector. It was that in both cases the people running the business made a long series of unglamorous capital decisions that a different management team would have made differently, and worse.

I shop at Dillard’s. I have bought Ralph Lauren there at deep discounts for years. Once I bought a Herschel suitcase with a $325 tag for $113, and the discount made me happier than the luggage did. Being a customer gave me a reason to look. It gave me conviction when the screen looked ugly. It did not give me the answer. The filings gave me the answer, and the part of the filings I underweighted was the management scorecard.

That is the gap I am closing this week.

Why I am not just copying Buffett

Sam Walton said he spent more time in his competitors’ stores than in his own. He was not there to admire them. He was there to take what worked, bring it back, and improve on it.

That is the method behind this whole week. Find whoever does a thing better than everyone else, understand exactly how, then build your own version that fits your situation. I am not writing a summary of Buffett’s views. I am building a guideline for vetting management that any subscriber can run, and he is the first source because he is the most documented, not because he is the only one.

He also has a specific gap, and it happens to sit exactly where I am hunting.

His own published acquisition criteria include a preference for simple businesses, with a parenthetical admitting that if there is a lot of technology involved he will not understand it. That is an honest limit and it has served him. But I am a value investor who leans toward the picks-and-shovels layer of a technology buildout, and I have some technology background of my own. A framework that routes everything technical to the too-hard pile cannot help me where I most need help.

So the second source is Philip Fisher, and Buffett has said openly that a meaningful part of his own approach came from him.

Fisher was the growth investor, working in technology companies in the 1950s and 1960s, and his fifteen-point checklist is heavily weighted toward management quality: depth of the team beyond one person, whether they plan on a long horizon or a short one, how they treat their people, and whether they are candid when things go wrong.

His research method is the one Sam Walton was practicing without the name. Fisher called it scuttlebutt. You learn about a business by talking to the people around it, meaning customers, suppliers, competitors, and former employees, rather than only reading what the company publishes about itself.

Management has every incentive to describe itself favorably. Their competitors have none. When the outside picture contradicts the official one, the contradiction is the finding.

That is not a soft technique. For most of us it is the only primary research available, and it is more accessible now than it was in 1958. Customer reviews, industry forums, job postings, employee reviews, and trade press are all scuttlebutt, and they are free.

Buffett gives me the discipline about records and capital. Fisher gives me a way to work in businesses that Buffett would decline to analyze at all. The guideline this week is built from both, and I will keep adding sources to it as I find people who do this better than I do.

What this week covers

Four places the record shows up, and one piece about what to do when there is no record at all.

Tuesday: capital allocation, the one job that cannot be delegated, and how to read ten years of a cash flow statement to grade it. Plus the force Buffett called the institutional imperative, which explains why decent, intelligent managers spend money badly without any villain in the story.

Wednesday: share buybacks, and the two conditions Buffett has said must both be true before a repurchase helps you. This is the record across a full cycle, and it is where the $665 billion number gets uncomfortable.

Thursday: candor, which is the record in a bad year. How a management team writes about its own mistakes, and what the proxy statement says about them that the annual letter never will. The letter is the words. The proxy is the receipts.

Friday: the exception. Sometimes I want to own a business whose management has no long record to read, because the business itself is extraordinary. That is a real situation and pretending otherwise is dishonest. So Friday asks what the business has to be worth before I will accept an unproven team, where I draw that line, and why the line has to be drawn in advance. The full scorecard closes the week.

The point of doing this before the price moves

I do not forecast crashes. I prepare for them. That means keeping cash ready and keeping a short list of businesses I understand well enough to act on quickly, so that when fear does the pricing I am not starting my research from zero.

A short list built only on business quality and valuation is half a list. The other half is knowing, in advance, which management teams I would trust with a decade of retained earnings and which I would not. That work is slow, it is unglamorous, and it is impossible to do properly in the middle of a panic.

History gives you the setup, not the date. The scorecard is something you can finish before either one arrives.

Two tracks, as always. I am hunting new great companies I do not own yet. And I want to buy more of the great ones I already own when they go on sale, and lower my average on the ones I intend to hold forever. Both tracks run through the same question, which is whether the people inside will treat my money the way I would.

Tomorrow, the one job.

Revenue up 454 percent, a real profit margin at the segment level, and a financing trick that quietly answers our biggest worry. The business is proving itself. The price is the problem, and this week has been a lesson in why those are different questions.

The Long View · Tuesday, 18 August 2026 · Nebius (NBIS), Q2 2026 grade

All week we have circled one idea, through IBM and now through a company at the opposite end of the spectrum: the difference between a good business and a good investment. IBM taught it from the value side, a company can be worth owning because the price is low enough to forgive being wrong. Nebius teaches it from the other side. Here is a business doing almost everything right, growing at a rate that stops conversations, and the open question is not whether the company is good. It plainly is. The question is whether any business, however good, is worth what this one costs.

What we said to watch, back in May

In May we ran Nebius through the Stock Story Firewall and classified it Needs Proof. Nebius builds AI cloud infrastructure, the GPU data centers that AI companies rent to train and run their models. A GPU is the specialized chip that does the heavy computation behind modern AI, and renting access to thousands of them is the picks-and-shovels layer of the AI boom.

The hidden assumption we identified was specific: that Nebius’s revenue is scaling fast enough, and holding onto customers well enough, to justify a premium valuation before its cash is consumed by the enormous cost of the buildout. The framework we prescribed was Unit Economics Durability, which asks not whether demand exists, it clearly does, but whether Nebius can serve that demand at a profit that survives as the buildout scales. We set five tests. The company just reported, and it is time to grade them.

Test 1: Is the growth real and accelerating

Published bar: quarter-over-quarter revenue growth staying strong, with the trajectory holding rather than fading.

The number: second-quarter revenue was $582 million, up 454 percent from a year earlier, with the AI Cloud segment alone up 514 percent. Against the prior quarter, revenue grew roughly 48 percent. Proven, without an asterisk. This is not a company coasting on one good quarter. The growth is enormous and it is still accelerating, which is exactly what the bar asked for.

Test 2: Is the recurring revenue base building

Published bar: annual recurring revenue growing, signaling customers committing rather than dabbling.

Annual recurring revenue, or ARR, is the annualized value of a company’s subscription and contracted revenue, a way of turning current run-rate into a forward number. The figure: ARR reached $3.0 billion at the end of the quarter, up about 56 percent from the prior quarter’s $1.92 billion. Proven. Customers are not just showing up for one-time workloads. They are committing, and the committed base is compounding fast.

Test 3: Do the unit economics truly work

Published bar: margins expanding or holding as capacity scales, proving Nebius earns its revenue rather than buying it with underpriced compute.

The number: the AI Cloud segment posted an adjusted EBITDA margin of roughly 50 percent, up from about 45 percent the prior quarter. Adjusted EBITDA is earnings before interest, taxes, depreciation, and amortization, a rough proxy for the cash a business throws off before financing and accounting charges, and adjusted means certain one-time items are stripped out. Proven, and this is the one that matters most. A 50 percent segment margin, rising, says Nebius is not discounting its way to growth. The core service is soundly profitable at this scale. That is the single strongest piece of evidence that the unit economics are real.

Test 4: Will the cash last through the buildout

Published bar: cash reserves holding up against the capital burn, without an obvious near-term need to raise dilutive equity.

This was our biggest worry, and it is where the quarter delivered a genuine surprise. The raw numbers look alarming at first: Nebius spent $5.66 billion on capital expenditure, the money laid out to build data centers and buy chips, in a single quarter, and raised its full-year capex target to a staggering $20 to $25 billion. Against roughly $8 billion of cash, that pace of spending should light a fire.

Except it is being funded in a way we had not fully credited. Roughly 70 percent of the quarter’s deals included customer prepayments, money customers pay upfront, covering 50 to 60 percent of the associated capital cost. Nebius expects more than $9 billion in such prepayments this year. That is why the company ended the quarter with its cash pile intact and $2.3 billion in positive operating cash flow, despite the $5.66 billion of capex. The customers are pre-funding a large share of the buildout. We are moving this from inconclusive toward proven, with one reservation: the model works as long as customers keep prepaying, which ties the cash runway to continued demand. But the fear that Nebius would burn itself dry and be forced to raise equity at a bad moment looks materially weaker than it did in May. This is the most important thing we learned this quarter.

Test 5: Is the backlog converting to revenue

Published bar: the contracted backlog growing and converting, rather than sitting as a headline number that never arrives.

Remaining performance obligations, or RPO, is the contracted revenue a company has signed but not yet delivered, the backlog. The number: RPO stands in the neighborhood of $40 billion, and Nebius signed four landmark deals in the quarter averaging more than a billion dollars each. That is enormous for a company this size. But it stays inconclusive, because the specific rate at which that backlog converts into recognized revenue was not clearly disclosed, and a backlog is a promise, not a sale, until it arrives. The size is staggering and encouraging. The conversion is the thing we still cannot fully verify.

The tally, and the state that holds

Three of the five tests came in clearly proven: the growth, the recurring base, and the unit economics. The cash-runway question, our biggest worry in May, moved substantially toward proven on the strength of the customer-prepayment model. Only the backlog conversion stays truly open. On the evidence alone, this was close to a model quarter, and Nebius remains Needs Proof only because the highest-stakes question, whether all of this endures at scale, cannot be answered by two great quarters. The business is doing the proving. It is proving.

And here is the mirror to IBM

Now the part that ties the week together, and it is the whole point. We spent Monday and Tuesday on IBM, a company we own because in 2020 its price was so low it demanded almost nothing go right. Nebius is the exact opposite situation. The business is arguably far more impressive than IBM’s, growing more than four hundred percent a year at a real margin. And yet it may be the more dangerous stock, because of price.

Nebius trades at roughly sixty times its sales. Not earnings, sales, and its historical median is closer to seven. At that price, essentially everything has to go right: the growth must continue, the margins must hold, the prepayments must keep flowing, the backlog must convert, and the demand must never soften. There is no margin of safety in a sixty-times-sales price. It is the mirror image of the IBM lesson. In 2020, IBM’s low price meant I could be wrong about a great deal and still win. At sixty times sales, a Nebius buyer has to be right about nearly everything, because the price has already priced in success, and then some. It is worth noting, quietly, that the people who know the company best have been net sellers of the stock in recent months. That is not damning on its own. It is one more data point in a picture where the price assumes perfection.

This is not a knock on Nebius the business. The business is extraordinary. It is an observation about Nebius the stock, and the difference between those two things is the most valuable idea we cover. A great company and a great investment are not the same, and the bridge between them is always the price.

What we watch next

The backlog conversion rate, quarter by quarter, because a $40 billion backlog only matters when it becomes revenue, and that is the one test still open.

The prepayment model, and who is behind it, because it is now central to the whole case, and this is where my real concern sits. The prepayments funding Nebius come from a very small number of very large customers, and those customers are themselves spending far more than they earn and borrowing heavily to do it. So the cash that makes Nebius look self-funding is riding on the continued willingness, and ability, of a couple of debt-stretched giants to keep pre-paying. As long as they do, the cash-runway fear stays contained. If even one of them pulls back, the enormous capex turns from a strength into a sharp risk, fast. That is the single thread I would watch above all others.

And the price, because at sixty times sales, the stock does not need bad news to fall. It only needs good news to arrive slightly slower than perfection.

The question this leaves open, and the piece coming tomorrow

So the price is the problem. But that raises the question every patient investor really cares about, the one this grade cannot answer on its own: if Nebius is this good and this expensive, and it may never stumble, then what could ever bring it down to a price worth paying?

Sit with that, because it is not a small question. A value investor could admire this company for years and never get a chance at it, if the only thing that would make it cheap is the company failing, and it never does. But there is another way a great company reaches a fair price, and it has nothing to do with the company at all.

Remember what I just told you about the concern. Nebius is funded by prepayments from two giants who are borrowing to pay it. Those giants borrow at rates set by the bond market. The bond market is moving, right now, for reasons that reach all the way from government deficits and foreign selling of U.S. debt to the price of every AI stock on your screen. There is a chain running from Washington’s borrowing to Nebius’s share price, and if it tightens, it could hand a patient investor this exact company at a price that finally works, without Nebius ever missing a beat.

That chain is the whole story, and it is too big to bury at the bottom of a grade. So it is tomorrow’s piece, in full: every link, what could set it in motion, and the specific conditions I would need to see before a company like this one becomes a buy. If the question of when a great AI company gets cheap has ever nagged at you, that is the one to read.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch cards, the Evidence tool, and the full Research Tracker, on the companies we own and the ones we do not.

Nebius proved almost everything we asked it to prove. The business is real, the growth is real, the margins are real, and the financing is cleverer than we gave it credit for. And it might still be a poor investment from here, because a magnificent company bought at sixty times sales is exactly the kind of thing this week was about. The company is not the question. The price is.

Not investment advice. The subscriber decides.

Disclosure: the author has held IBM since March 2020 at an average cost of $113.57 and reinvests the dividend. Independent dividend analysis contributed by Dave Ahern of Dividend School. This is analysis and a bar set before results, not a recommendation.

Yesterday’s piece was the easy one to write, because it had a happy ending. This one is harder, because it refuses to let that happy ending decide anything. The most dangerous thing a long-term investor can do is let a stock’s past generosity buy it a permanent place in the portfolio. A holding earns its spot every year on its current merits, not on what it did for you five years ago. So today I set the bar IBM has to clear, in public, and I grade it against those exact lines when it reports, no more gently for the fact that I own it and it has treated me well.

Why the bar matters more now

IBM is not the company I bought. The 2020 business was a deeply cheap turnaround with a fortress dividend and a new cloud strategy. Today it is a hybrid-cloud and enterprise-AI company, and it has had a punishing year that is worth walking through, because the year itself teaches the lesson.

IBM entered 2026 near its highs, above $300 a share, after a strong 2025 that saw the stock climb roughly 35 percent. Then it took two separate blows. In February, it fell about 13 percent in a single session after a competitor announced an AI coding tool aimed squarely at the legacy-system modernization work that is part of IBM’s core consulting business, a real threat to a real revenue line. Then in July, it fell about 25 percent in a day, its sharpest single-session drop on record, after warning on second-quarter results, weak mainframe sales and a cut to full-year revenue-growth guidance. From above $300 to around $236 now, the stock is down roughly 19 percent on my cost basis for the year, and it sits well off where it started. Shareholder law firms opened the kind of investigations that routinely follow a sharp drop; that is a matter of public record, and I note it plainly and draw no conclusion, because there is nothing yet to conclude.

Here is why that year-to-date decline is not a digression but the whole point. IBM entered 2026 expensive, priced near the top of its range with little margin of safety built into the price. So when the two shocks came, there was no cushion to absorb them, and the stock fell hard and fast. That is the exact mirror of my 2020 purchase, where a rock-bottom price meant bad news had far less room to hurt. The year you are watching, in real time, is a live demonstration of what it looks like to own a good company without a margin of safety when trouble arrives. Which is precisely why the price today, and the bar the business now has to clear, deserve a hard look.

I did not sell into that drop, and to explain why, I have to tell you what kind of investor I am. Warren Buffett put it best, in his 1996 letter to shareholders: if you aren’t willing to own a stock for ten years, don’t even think about owning it for ten minutes. That is not a slogan to me, it is the whole posture. When I buy a business, I buy it as something to hold through good years and bad, crashes and boring stretches, on the assumption that I will own it for a decade or longer. An investor who thinks that way does not sell a good company because it had one ugly quarter, any more than a farmer sells the farm because it did not rain this season. A single disclosure about deferred deals is precisely the kind of near-term noise that a ten-year owner has to be able to sit through.

But, and this is the part that keeps the Buffett quote from becoming an excuse, sitting through noise is not the same as ignoring the signal. Owning for ten years does not mean owning blindly for ten years. It means holding through short-term turbulence while still checking, with clear eyes, whether the ten-year story is intact. The disciplined response to a 25 percent drop on a stock you intend to own for a decade is neither to panic and sell nor to shrug and look away. It is to define, precisely and in advance, what the next report has to show for the long-term thesis to still hold. So let me do that.

What margin of safety looks like, then and now

Before I set the bar, look at what has changed about the price, because this is the heart of it. I started buying IBM on March 23, 2020, the worst day of the COVID crash, at $93.49 a share, and I kept buying, which brought my average cost to $113.57. At that first purchase I was paying about ten times earnings, with a dividend yield above 6 percent that was well covered. Against the company’s own ten-year average of around twenty-six times earnings, that was an enormous margin of safety. The price was so low that I did not need much to go right, and when one of my reasons failed, the cheapness absorbed the blow. In 2020, the price protected me.

Today is a different picture, and honesty requires saying so plainly. IBM trades at roughly twenty times trailing earnings, with a dividend yield near 2.9 percent. That is still below its historical average, and by at least one common measure the stock looks roughly fairly valued, neither expensive nor a bargain. This is the crucial lesson, and it is the same company teaching it: the margin of safety was never a property of IBM. It lived in the price. At ten times earnings with a 6 percent yield, IBM offered a fat cushion. At twenty times with a 2.9 percent yield, that cushion is thin. The business is arguably better today, more focused, more profitable, but the protection I enjoyed in 2020 has largely been paid away by a higher price.

There is one more piece of this worth teaching, because it surprises people and it is the quiet reward for buying low. You will notice IBM’s yield went from above 6 percent in 2020 to about 2.9 percent today, and it is worth understanding why, because it is not what it looks like. The yield did not fall because IBM got stingy. The dividend rose over those years. The yield fell because the price more than doubled, and yield is simply the dividend divided by the price. When the bottom of that fraction grows faster than the top, the yield shrinks, even as the payout climbs. A 2.9 percent yield today and a 6 percent yield in 2020 can be the very same dividend, seen at two very different prices.

But here is the part that rewards the patient buyer. My yield is not 2.9 percent. That is the yield a new buyer gets at today’s price. My yield is measured against what I paid, which is called yield on cost, and against my $113.57 average it is closer to 5.9 percent, and against my first shares at $93.49 it is around 7 percent. Same dividend, but because I bought at a low price, I locked in a high yield that rising prices can never take back. This is one of the most underappreciated rewards of buying with a margin of safety: a low entry price does not just protect you on the downside, it permanently raises the income you earn on every dollar you invested, for as long as you hold. New money buys IBM’s dividend at 2.9 percent. My money, bought in the panic, still earns almost twice that.

Here is why that matters for what comes next. When the price gives you a wide margin of safety, the price does the protecting, and the business can stumble without ruining you. When the price is merely fair, the protection has to come from somewhere else: the business executing. At today’s valuation, I am no longer being handed a cushion. I am paying a fair price and trusting the company to deliver, which means the burden shifts from the price to the performance. That is precisely why the bar matters more now than it did when I bought. In 2020 I could be patient and let a cheap price carry me. Today, IBM has to earn it. So here is what earning it looks like.

The bar for October

IBM reports its next quarter on October 21. Here are the five lines, set before the numbers exist. Each has a level that confirms the thesis and a level that breaks it.

Software recurring revenue growth. IBM’s software segment carries annual recurring revenue, or ARR, the annualized value of its subscription contracts, currently around $24.6 billion growing about 8 percent a year. Growth at or above 10 percent confirms the compounding lock-in the whole story depends on. Growth below 6 percent signals the stickiness is eroding.

Red Hat growth. Red Hat, the hybrid-cloud engine, has been growing around 11 percent, with OpenShift’s recurring revenue near $2.2 billion. At or above 12 percent confirms enterprises are still adopting the platform. Below 7 percent signals it is being commoditized or pushed aside by bigger cloud rivals.

Full-year guidance. IBM already cut its constant-currency revenue-growth guidance, the growth rate stripped of currency-exchange swings, from above 5 percent to a range of 4 to 5 percent this year. Holding at or above 5 percent confirms. A second cut, or new caveats about enterprise spending, would be a serious credibility problem.

Free cash flow. Free cash flow, the cash a business generates after funding its operations and investments, is what pays IBM’s dividend and services its debt. IBM targets roughly $12 billion or more for the year. At or above $12 billion confirms the cash engine is intact. Tracking below $10 billion annualized signals deterioration.

Insider buying. After a 25 percent drop, the cleanest signal of conviction would be a named insider buying shares in the open market with their own money. Continued absence is not damning, but a purchase would say something no press release can.

Five lines. All pending until October 21. That is the bar, set in public, today.

The dividend I have to keep honest about

The dividend is why I have been content to hold through a bad year, so it is exactly the thing I have to watch most carefully, because comfort is where discipline goes to die. IBM yields around 2.9 percent today, has raised the payout for about thirty consecutive years, and I reinvest it every quarter, which means this year’s decline has quietly been buying me cheaper shares the whole way down. That is the good side. But a long streak is a point of pride companies will stretch to protect, and the honest question is whether it is funded by cash the business earns or partly by borrowing, especially with long-term debt around $56 billion after recent acquisitions.

This is where an outside view matters, because I am too invested to trust my own. Dave Ahern of Dividend School gave me his read, and on the forward question it is reassuring with one flag worth teaching in full, because it applies to any dividend stock you will ever own.

First, the reassuring part. Dave checks three things, and IBM passes all three. The free-cash-flow payout, the share of actual cash the dividend consumes, sits well below his 70 percent threshold for concern, so the cash covering the dividend has real room. Net debt is about 2.9 times EBITDA, a company’s earnings before interest, taxes, depreciation, and amortization, which is a standard way to size debt against a rough proxy for cash earnings, and 2.9 times is a level he considers fine. And interest coverage, how many times over the company’s earnings can pay the interest on its debt, is around 6 times, which he considers good. Together those say the dividend is not being squeezed by the debt today.

Now the flag, and this is the part I want every reader to carry away, because it is the single most useful early-warning sign for a dividend. Dave’s caution is that IBM’s dividend has been growing slightly faster than its free cash flow. Here is why that matters. A dividend is paid out of cash. The room between the cash a company generates and the dividend it pays is the safety cushion. If the dividend grows faster than the cash behind it, year after year, that cushion narrows, slowly, quietly, in a way that looks fine every single year right up until it does not. The payout ratio creeps from comfortable toward stretched, and one bad year can then turn a proud streak into a hard choice between cutting the dividend and borrowing to pay it. It is not a problem when the coverage starts wide, as IBM’s does. It becomes a problem through repetition, a percent or two a year, until the margin is gone.

So here is how you check this yourself on any dividend stock, and it is simple. Find the growth rate of the dividend over the last five years, and find the growth rate of free cash flow over the same period. If free cash flow is growing at least as fast as the dividend, the cushion is holding or widening, and the dividend is being earned. If the dividend is consistently outgrowing the cash, the company is writing checks its business is not yet backing at the same pace, and you are watching a cushion deflate. It does not mean sell. It means watch, and know the number that would turn a watch into a worry. For IBM, that number is free cash flow. If October shows it holding at or above roughly $12 billion, the dividend’s cushion has room and the streak is funded by the business. If it slips toward $10 billion while the dividend keeps climbing, the gap Dave flagged starts to bite, and the safest dividend on my holdings becomes one I have to question. That is the whole discipline of dividend safety in one comparison: is the cash growing as fast as the promise.

What would truly change my mind

Here is the part that keeps this honest. It is easy to say you will grade a holding strictly. It is hard to say, in advance, what would make you let it go. So: if IBM cuts guidance a second time in the same year, if software and Red Hat growth both fall toward their break levels, or if free cash flow drops far enough to put the dividend’s coverage in question, then the thesis I have held since 2020 is weakening in a way that price alone cannot excuse, and I have to treat it as a business in trouble rather than a winner having an off year. I am not predicting that. I am telling you the conditions under which I would change my mind, because an investor who cannot name those conditions is not holding a position, they are married to it.

The through-line from yesterday

Part one was about how a low price forgave a mistake. Part two is about not needing that forgiveness again through carelessness. In 2020 the margin of safety was enormous, ten times earnings, a 6 percent covered yield, and it made me hard to hurt. Today the price is not that, the easy protection is gone, and what replaces it is discipline: a bar set in public, a dividend watched by someone without my attachment, and a written list of what would make me sell. That is how you hold a long-term winner without becoming its hostage.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch cards, the Evidence tool, and the full Research Tracker, including every bar we set and every grade we publish.

The stock has been good to me for five years. That is exactly why I have to be hardest on it now. In October, IBM reports, and I will grade it against the five lines above, and find out whether the company I own on its history is still the company I would own on its merits.

Not investment advice. The subscriber decides.

In March 2020 I bought a 109-year-old company at about ten times earnings, an eleven-year low, paying a dividend yield above 6 percent that was well covered, with a fresh cloud strategy and a working AI. One of my reasons for buying, the AI, later collapsed. The investment still returned more than 200 percent, and the reason is the most important idea in value investing: a price low enough is a margin of safety wide enough to forgive being wrong.

Disclosure: the author has held IBM since March 2020 at an average cost of $113.57 and reinvests the dividend. Independent dividend analysis contributed by Dave Ahern of Dividend School, printed unedited. This is analysis, not a recommendation.

This is the first of two pieces on a company I have owned for five years. This one is the story, and the lesson inside it. The second, tomorrow, is the discipline: the bar IBM has to clear to keep its place in the portfolio. You cannot understand the second without the first, so let me start where I started, at the bottom of a crash, with a stock almost nobody wanted.

What IBM looked like in March 2020

Cast your mind back. The COVID crash was tearing through the market, and IBM, already an unloved stock, fell to its lowest point since 2009, an eleven-year low. On March 23, the worst day of that crash, I started buying at $93.49.

Here is what I was buying, in the language of value. IBM’s price had fallen to roughly ten times its earnings. To put that in perspective, over the previous decade IBM had traded at an average of about twenty-six times earnings, so I was buying it at well under half its own normal valuation. The dividend yield, the annual dividend divided by the share price, had climbed above 6 percent, because when a price falls far enough, the fixed dividend becomes a larger and larger share of it. And that dividend was not a fragile promise. IBM had raised it for twenty-four straight years, and it was consuming less than half of the company’s free cash flow, the cash left after running and investing in the business, and about 61 percent of earnings. A well-covered 6 percent yield on a 109-year-old company at ten times earnings. That is not a lottery ticket. That is a value.

The reasons I bought, and I want to be honest that there were several

I did not buy IBM for one reason, and being straight about that is the whole point of this piece.

The business case had real parts. IBM had just closed its $34 billion acquisition of Red Hat in July 2019, and it was building a hybrid-cloud strategy, the business of helping big companies run their computing across their own data centers and multiple public clouds at once, with Red Hat’s OpenShift platform as the engine. Not public cloud, IBM had already lost that race to Amazon and Microsoft, but hybrid cloud, a specific corner where IBM was positioned to lead. Alongside that was Watson, IBM’s artificial intelligence, and it was not a slide in a pitch deck, it was a working system being used in real applications, including cancer research, and its potential looked enormous.

So the case was: a deeply cheap price, a fortress dividend, a credible new cloud strategy, and a working AI with a huge runway. Several independent reasons to own it, bought at a price that demanded almost nothing go right.

The part I got wrong

Now the honest part. The Watson story, specifically Watson in healthcare, the piece I found most exciting, became one of the most expensive disappointments in IBM’s modern history. The company had poured roughly five billion dollars and thousands of people into Watson Health, the marquee hospital partnerships faltered, and in 2022 IBM sold those assets to a private equity firm for around one billion dollars, a fraction of what went in.

One of the reasons I bought IBM did not just underperform. It failed outright.

Why it worked anyway

And the investment still returned more than 200 percent. Sit with how those two facts coexist, because the space between them is where value investing really lives.

It worked for two reasons, and they are the same reason wearing two hats. First, the parts I got right, the cheapness, the dividend, the hybrid-cloud repositioning, were the durable ones, and they carried the whole. Second, and underneath everything, the price. I paid about ten times earnings for a profitable, cash-generating business. At that price, I was not depending on Watson to save me. I was being paid a well-covered 6 percent every year just to wait, on a business with several other ways to win. So when one of those ways collapsed, it cost me a piece of the upside, not the investment. The margin of safety absorbed the mistake.

That phrase, margin of safety, is the oldest idea in value investing, and it means buying so far below what a business is worth that you can be wrong about part of your thesis and still come out fine. It is insurance you buy with a low price. If I had paid a premium in 2020 and leaned the entire case on Watson, its failure would have been a wound. Because I paid a crash price for a business with multiple engines and a fat, covered dividend, the failure was a footnote.

An independent look at the dividend that anchored it

Because the dividend was so central to why this worked, and because I have reinvested it every quarter for five years and am therefore too attached to judge it cleanly, I asked someone who is not. Dave Ahern, who writes Dividend School, gave me his honest read, printed as he sees it.

His verdict was that IBM’s payout looks fairly safe. The scary-looking number is the earnings payout ratio, which has run above 100 percent in four of the last ten years, meaning IBM paid out more in dividends than it booked in reported profit in those years. Dave calls that not awesome, but not a killer, and here is why: he weights free cash flow over earnings, because a company like IBM carries heavy non-cash charges that make reported profit understate the actual cash coming in. On that truer measure, IBM’s free-cash-flow payout has stayed well below 70 percent, his threshold for concern. The cash covers the dividend even when earnings optically did not. He flagged one thing to watch, dividend growth is running slightly ahead of free-cash-flow growth, which slowly narrows the cushion over time. That is the honest kind of caution I wanted and could not have given myself. My thanks to him for the outside eyes.

The point for this piece is that the dividend was not decoration on the value case. It was a load-bearing part of it, then and now. A 6 percent yield you can trust is a huge share of the margin of safety, because it pays you to be patient while the rest of the thesis plays out, or does not.

The lesson, stated plainly

Here is what I want you to take from this, because it is the truest thing I know about investing, and it runs against how most people think about being right.

You do not have to get the story completely right to do well. You have to get the price right enough that being partly wrong cannot ruin you. I was wrong about the single most exciting reason I bought IBM. In most framings of investing, being wrong about your thesis means you lose. But value investing is not built on being right about the future. It is built on paying so little for the present that the future has many ways to reward you and few ways to hurt you. The margin of safety is not a nice-to-have. It is the whole mechanism by which ordinary investors survive their own mistakes, and everyone makes them.

Buy a good business at a punishing price and you need everything to go right. Buy a good business at a genuine discount, with a covered dividend paying you to wait, and you can be wrong about a great deal and still win. That is not a trick. It is the entire discipline, in one holding.

Tomorrow, the harder half

None of this tells me whether IBM still deserves its place in my portfolio today. That is a different question, a forward-looking one, and it does not get the gentle treatment just because the position has been good to me. The stock recently fell 25 percent in a day on a real disclosure, and it reports again in October. Tomorrow, I set the bar it has to clear, in public, before the numbers, and I grade it no more gently for owning it. The value that forgave my mistake in 2020 does not entitle IBM to anything now. Today it earns its place or it does not, and that is part two.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch cards, the Evidence tool, and the full Research Tracker, on the companies we own and the ones we do not.

I was half wrong about why I bought IBM, and at ten times earnings, with a 6 percent dividend paying me to wait, it barely mattered. Remember that the next time someone tells you investing is about being right. It is about being wrong safely, and the price is what makes the safety.

Not investment advice. The subscriber decides.

Returns above 10 percent across all its divisions, not just the good ones. It cleared that bar with room to spare. Then, on results day, ten insiders including the chairman did something our pre-earnings read said they were not doing. This is a different kind of company from the software names we graded this week, and it asks a different question.

All week we have been in software, where the questions are growth rates and customer concentration. Barclays is a British universal bank, a different animal, and grading it means a different lens. A bank does not live on revenue growth. It lives on the spread between what it earns on its assets and pays for its funding, the quality of its loans, and the capital cushion regulators require. So the bar we set in July was built from a bank’s vocabulary, and to grade it fairly, we define that vocabulary as we go.

The one thing the story depended on

We published a Watch card on Barclays on the thirteenth of July, and named the hidden assumption its price rested on: that Barclays can sustain a return on tangible equity above 10 percent across all three of its major arms, its UK retail bank, its investment bank, and its US consumer business, while growing income toward its targets.

That phrase, return on tangible equity, is the single most important number for a bank, so let us define it plainly. Return on tangible equity, or RoTE, measures how much profit a bank generates for every dollar of hard shareholder equity it holds, stripping out intangible items like goodwill. It is the banking world’s version of asking how good a return the business earns on the real money invested in it. A RoTE of 10 percent is the rough line between a bank that is worth its equity and one that is quietly destroying value. Above it, the bank earns more than its cost of capital. Below it, ownership is a slow leak. Barclays’ whole story, and its price, rested on holding above that line everywhere, not just in the strong divisions.

We classified it Watch. Here is the grade.

Test 1: Did returns hold above the line

Published bar: return on tangible equity sustained above 10 percent across the divisions, with group income growing toward guidance.

The numbers: group RoTE came in at 16.1 percent for the second quarter, and 14.8 percent for the first half. Management raised its full-year income guidance to roughly £31.5 billion. Proven, decisively. This is not 10 percent scraped by in one favorable division. It is mid-teens returns at the group level, well clear of the line, with the income trajectory rising rather than fading. The core bet the price depended on came in strong.

Test 2: Is the UK engine running

Published bar: UK net interest income holding near its roughly £7.6 billion annual run-rate.

Net interest income, the next term to define, is the difference between the interest a bank earns on its loans and the interest it pays on deposits and other funding. For a retail bank it is the core profit engine, the spread that turns deposits into earnings. When it grows, the bank’s foundation is solid; when it shrinks, everything else has to work harder to compensate.

The number: Barclays’ UK net interest income was £3,986 million for the first half, an annualized pace near £7.97 billion, with full-year guidance of £8.1 to £8.3 billion. Proven. The engine is not just running, it is running slightly ahead of the run-rate we flagged, and guidance points higher still.

Test 3: The one that did not fully clear

Published bar: the US consumer bank’s credit-loss trend staying contained.

One more definition, because it is the crux of this test. A credit-loss rate, sometimes called an impairment or loss rate, is the share of a lender’s loans it expects not to be repaid, expressed against the loan balance, often in basis points, where one basis point is one hundredth of a percent. It is the single clearest read on whether a lending book is healthy or deteriorating. Rising loss rates mean borrowers are struggling; falling ones mean the book is improving.

The numbers, and why they are mixed: the US consumer bank’s impairment charge for the first half was £713 million, essentially flat against £711 million a year earlier. The loss rate ran at 555 basis points, an improvement from 562 a year ago, but up from 491 basis points in the prior quarter. Thirty-day arrears, the share of borrowers a month behind, sat at 2.9 percent, a touch above the prior year. Inconclusive. Better than a year ago, worse than last quarter. This is the one place the story is not yet settled, and it is the exact risk the Firewall flagged in July: a US consumer credit-card book is directly exposed to American household stress, and the quarter-on-quarter tick upward is the thing to watch. Not a break. Not a clean pass. An open question.

Test 4: The capital cushion and the cash it returns

Published bar: the core capital ratio holding within its target range while funding the promised shareholder returns.

The final term: CET1, or common equity tier one, is the ratio of a bank’s highest-quality capital to its risk-weighted assets. It is the cushion regulators require to absorb losses, and the number that determines whether a bank can afford to pay dividends and buy back stock. A bank returning cash it cannot spare is asking for trouble; one doing it from a position of strength is compounding for shareholders.

The numbers: Barclays’ CET1 ratio was 14.3 percent at the end of June, comfortably inside its 13 to 14 percent target, and 14.0 percent after accounting for a £1 billion buyback. It announced that £1 billion share buyback plus an £800 million interim dividend. Proven. The bank is returning substantial capital from a position of real strength, not stretching to do it.

The twist: what the insiders did

Here is where this grade gets its edge. When we published the Firewall on Barclays in July, our insider read came back neutral. The only transactions we could find were routine, compensation-related disposals, nothing that signaled conviction. So we flagged insider activity as neutral, and said so.

Then Barclays reported on the twenty-eighth of July, and on that very day, ten named senior insiders bought shares in the open market, at £4.974 each. Not granted. Not vested. Bought, with their own money, on results day. Among them was the group chairman, Nigel Higgins. When ten insiders including the chairman put personal capital into the stock on the day results land, that is the kind of signal our neutral July read did not have, and honesty requires us to update it. The insider picture is no longer neutral. It flipped, and it flipped toward conviction.

The tally, and the state that holds

Four of the five checks came in proven: returns well above the line, the UK engine running ahead of pace, capital strong and cash flowing to shareholders, and insiders buying with conviction. The fifth, US consumer credit, is truly inconclusive, better on the year, softer on the quarter. Barclays remains Watch, an honest one, because the core bet is proven and the one open risk is real rather than cosmetic.

The value question a bank like this poses

Now the part that makes Barclays interesting to a value investor, and it is a different question from anything we asked this week. Barclays trades at roughly the value of its own tangible equity, near one times tangible book value. Book value is what the company’s assets are worth on paper after subtracting what it owes; for a bank, trading at one times book means you are paying roughly the accounting value of the equity itself.

Put the two facts together. Here is a bank earning around 15 percent on its tangible equity, and you can buy that equity at approximately its book value. If those returns hold, you are buying a mid-teens return stream at the price of the underlying capital, which is the classic case for a value bank. That is a real draw, and it is why the stock has already risen more than 50 percent this year as the market began to notice.

But a value investor says the hard part out loud too. Banks trade cheap for reasons. Their earnings are cyclical, their loan books carry credit risk that surfaces exactly when times get hard, and a mid-teens return can compress quickly in a downturn. The US consumer credit trend we just flagged is precisely the kind of thing that turns a cheap bank into a value trap, a stock that looks inexpensive right up until the returns fall and the cheapness turns out to have been deserved. Barclays has the profile of value. Whether it is value or a trap depends on whether those returns hold, and the credit question is where that is decided.

What we watch next

The US consumer credit-loss rate, quarter by quarter, because it is the one number that would move Barclays from a proven Watch toward either a clearer value case or a warning. If it stabilizes, the value story strengthens. If it keeps climbing, the trap risk grows.

And the price against book value, because much of the easy re-rating has happened. The clearest value was available when the market was fearful and the stock traded well below book. Near book value, earning mid-teens returns, it is still reasonable, but it is no longer the obvious bargain it was, and the discipline is to know the difference.

We named the one thing in July: returns above the line, everywhere. Barclays proved it, added a capital return from strength, and saw its own insiders buy on results day, updating the neutral read we had reported plainly before the print. The one open question, US consumer credit, is the one that will decide whether a cheap bank stays a value or becomes a trap. That is the grade, against the bar we published, in a bank’s own language.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch cards, the Evidence tool, and the full Research Tracker, including every test we have published and how each one scored.

A bank earning 15 percent on its equity, priced near the value of that equity, is the kind of thing a value investor is built to notice. Whether it is a bargain or a trap is a question of whether the returns hold, and this quarter answered most of that question, and left one piece of it open.

Not investment advice. The subscriber decides.

Disclosure: the author has held shares of Dynatrace since September 2022. This is an analysis of a risk, not a recommendation on either stock.

Here is a question worth more than most of the AI commentary you will read this year. When a company is called an AI winner, and its stock is priced as though the winning will continue for a decade, what exactly is that future built on. Not the technology, everyone talks about the technology. The money. Who is paying, with what, and for how long can they keep it up. Ask that question across the AI trade and you find the same answer in a lot of places: an enormous amount of assumed future revenue traces back to a small number of large buyers who are spending borrowed money on hardware that keeps getting more expensive, betting the revenue shows up before the loans come due. That is a real risk, and it is strangely absent from the prices. The clearest way to see it is through two companies that do the same thing and are priced as opposites.

The company one customer could move

Start with the one that just proved the point. When Datadog reported, it disclosed that its single largest customer, which the company does not name but which analysts widely believe to be OpenAI, had reduced its usage. Not left. Not churned. It renewed a nine-figure contract in the same quarter. It simply used less. And that one customer optimizing its spend was enough, combined with slightly softer guidance, to take about 17 percent off a company worth roughly $90 billion, in a single trading session.

Sit with the proportion. One customer, still under contract, still paying, dialed back its consumption, and a sixth of the company’s market value evaporated in a day. That only happens when a meaningful slice of the growth depends on a small number of very large accounts. It is called customer concentration, the degree to which a company’s revenue leans on a handful of big buyers rather than being spread across many, and it is one of the oldest risks in business analysis. What is new is where it is hiding now.

Why Dynatrace cannot fall the same way

Now look at the competitor. Dynatrace sells the same kind of software to a different kind of base. Its customers are, in its own words, many of the world’s largest enterprises, and its sales effort targets the largest 15,000 companies on earth, across banking, government, retail, and industry. Its revenue is spread across thousands of large, diversified enterprise relationships, the kind that sign multi-year platform commitments and embed the software into how they run.

That structure has a specific consequence. No single Dynatrace customer is large enough to take 17 percent off the company by trimming usage, because the revenue is not concentrated that way. A diversified base grows slower, it is less exciting, it does not ride the vertical AI-spending wave the way a concentrated AI-native book does. But it also cannot be knocked over by one buyer’s decision. What Dynatrace gives up in explosive growth, it gets back in the one thing a value investor prizes most: durability.

The prices say the opposite of the risk

Here is where it gets interesting for anyone who thinks about price, which is the whole of what we do. Datadog, the company with the concentration risk, trades at roughly 90 times forward earnings. Dynatrace, the company without it, trades around 22 times. The market is paying a large premium for the business whose growth is more fragile, and a discount for the business whose growth is more durable.

That is backwards from how risk should be priced. A concentrated revenue base is riskier, and risk should command a lower multiple, not a higher one. Instead, the concentration comes bundled with faster growth, and the market has decided that growth is worth almost any price while treating the fragility underneath as though it were not there. Datadog is priced as if the concentration is not a risk at all. Dynatrace is priced as if nothing good will ever happen to it. The truth about the risk in each is the reverse of what the prices imply.

We are not saying Datadog is a bad business. It is a superb one, growing faster than Dynatrace, with higher margins. We own the point more narrowly: the price you pay should account for the risk you take, and in Datadog’s case it does not, which is why one customer’s ordinary decision could take 17 percent off it in a day. The business is excellent. The price is not accounting for how its growth is built.

The part that is bigger than either company

Now widen the lens, because this is the reason the week’s two grades belong in one piece. Datadog is not the only company whose value leans on a small number of AI-native buyers. It is just the most visible one, because it reports cleanly and the market reacted violently. The same shape runs through a large and growing slice of the AI trade.

Consider Nebius, whose story rests on a $27 billion contracted backlog, a huge share of it tied to a single counterparty, Meta. Or the wider constellation of AI-infrastructure names, the data-center builders, the GPU-cloud providers, the tooling layers. A striking amount of their assumed future revenue traces back to the spending plans of a small handful of AI-native companies, OpenAI foremost among them, whose consumption is modeled forward as if it will only ever rise, only ever stay, and only ever be spent with them specifically.

That is the hidden assumption underneath a big part of the AI trade: that a few enormous buyers keep consuming, keep growing, and keep buying from the same vendors, indefinitely. It is the same kind of single load-bearing belief our whole method exists to find. For one session, on the day of that report, the market remembered it was load-bearing, and then went back to forgetting.

The caveat that makes it sharper: the buyers are borrowing

Here is what turns concentration from a structural fact into a live one, and it is the present environment, not a forecast. The AI-native companies underneath this trade are, in many cases, funding their own buildout with debt, at a moment when the hardware is getting more expensive, not less. The numbers are not small. Technology companies issued a record $428 billion in bonds in 2025, and JPMorgan projects AI-related debt financing could reach $4.1 trillion as loan-to-cost ratios rise, with some AI companies borrowing at double-digit coupons. At the same time, the key AI memory chips are sold out through 2026 and the cost of building data-center capacity is climbing. Four U.S. senators have publicly warned that Big Tech’s turn to complex, opaque debt markets could cause destabilizing losses. This is the environment as it exists today, and it is verifiable.

Now connect it to the vendors. A company like Datadog does not carry that debt. But its largest customers do, or their spending depends on those who do. The whole AI buildout is running on roughly thirteen dollars invested for every one dollar of current AI revenue, a bet that the revenue catches up to the spending, financed increasingly by borrowing. When the money is cheap and flowing, those customers spend freely, and their vendors grow beautifully. When capital tightens, or the return on all that spending is questioned, the first thing a cash-conscious AI company does is optimize its spend. Which is precisely what Datadog’s largest customer just did. The usage cut that took 17 percent off the stock was not a random event. It is what the beginning of spending discipline looks like, in an industry funding itself on debt, flowing downhill to the vendors who depend on it.

So the concentration risk and the debt environment are the same risk seen from two angles. Your revenue depends on a few large buyers, and those buyers are spending borrowed money on hardware that keeps getting pricier, betting on a payoff that has not arrived yet. A vendor does not need to carry a dollar of that debt to be exposed to it. It only needs its customers to.

And here is the turn, because this is not a doom story

Now the question a value investor should be asking, and it is the hopeful one. Datadog is a magnificent business. We do not own it because the price demands perfection. But what if this very environment, the debt pressure, the spending discipline, the concentration finally being noticed, is the thing that eventually brings Datadog to a price that accounts for its risk. If the AI-native cohort tightens, and Datadog’s growth cools from spectacular to merely strong, and its multiple compresses from ninety times toward something reasonable, then the magnificent business we admire but will not overpay for could finally become the value we have been waiting for. We are not rooting for anyone’s pain. We are saying the discipline that keeps us out of Datadog today is the same discipline that would let us in tomorrow, at a price that finally makes sense. The great company does not have to stay too expensive forever. Sometimes the environment does the repricing for you, and the patient buyer is there when it does.

What this does and does not mean

Let us be careful, because the truth protocol matters most here. This is not a prediction that the AI trade collapses, or that Datadog falls further, or that these customers cut spending. We do not know any of that, and anyone who claims to is selling something. The point is narrower, and it is the value investor’s point: a real concentration risk exists, it is spread across a large part of the AI-adjacent market, and the prices in many of these names are not accounting for it. When a price assumes a risk away, you do not need the risk to blow up to lose money. You only need the market to remember, briefly, that it is there, the way it did for one session on the day of that report. A stock priced for no concentration risk has only one direction to move when the concentration is noticed, and it is not up.

Where this leaves the two companies

Datadog stays what it was: a magnificent business at a price that assumes its growth is both durable and diversified, when its latest quarter showed it is neither as diversified nor as smooth as the multiple implies. Watch, on price, now with the concentration risk made visible rather than theoretical.

Dynatrace stays what it was too: profitable, growing slower, diversified, and priced as though the market cannot find a reason to care. For a value investor, the durable-and-ignored business is the more comfortable thing to own than the fragile-and-adored one, not because it will grow faster, but because no single customer’s Tuesday decision can take a sixth of it away. Disclosure, again: we hold Dynatrace, and we would rather own the concentration it does not have than the growth it cannot match.

What we watch, across all of it

Whether more large AI-native accounts optimize usage, at Datadog and across the AI-infrastructure names, because that pullback may be the first tremor or a one-off.

Whether any of these companies diversify their revenue away from the concentrated AI-native cohort, which would truly reduce the risk rather than merely postpone it.

And the prices, because the entire point is that risk should be paid for, not paid up for. The day one of these concentrated-growth stories is available at a price that accounts for its concentration, it becomes a value question worth asking. Until then, the market is buying the growth and ignoring the fragility, and we are watching, and naming what the prices are pretending is not there.

One customer, still under contract, used a little less software, and a $90 billion company lost a sixth of its value in a day. That is not a Datadog story. It is a window into how much of the AI economy’s value rests on how few buyers, and how little of that risk is in the prices. We do not know when it matters again. We know it is there, and that knowing is the whole job.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch Cards, the Evidence tool, and the full Research Tracker, including every company named here and where each one sits.

The best business is not always the safest one, and the safest one is rarely the most exciting. Price is supposed to tell you which risk you are taking. Right now, in two competitors and a whole industry behind them, the prices are telling you the opposite of the truth.

Not investment advice. The subscriber decides.

It grew ARR 17 percent, raised guidance, expanded margins, and bought back stock. And retention, the one number that mattered, ticked down to 110 percent. So the puzzle holds: excellent, cheap, and still waiting for the market to care. I have owned it since 2022, and I am going to grade it straight anyway.

Disclosure: the author has held shares of Dynatrace since 23 September 2022, at a cost of $33.21. This is a grade against a published bar, not a recommendation, and the discipline demands it be graded no more gently for being owned.

Yesterday we graded Datadog, the company that has to be perfect forever, which reported a flawless quarter and fell 17 percent. Today we grade its quieter competitor, the one I own, and the contrast is the reason this whole week exists. Before Dynatrace reported, we published a piece calling it “The Profitable Company Nobody Wants,” and we named the single thing it had to prove. This is the grade against that bar. And because I hold the stock, it gets the harder read, not the softer one.

The bar we set, before the number

Dynatrace is the mirror image of Datadog. Where Datadog is priced for perfection, Dynatrace is priced like the market has already decided the story is boring: profitable, growing in the mid-teens, and trading at a fraction of its flashier rival’s multiple. So the bar was different. Datadog had to stay flawless. Dynatrace only had to prove the business was not quietly deteriorating underneath a cheap price.

We set it precisely, and one term is worth defining first, because the whole grade turns on it. Annual recurring revenue, or ARR, is the annualized value of a software company’s subscription contracts, the run-rate of revenue it can expect to keep collecting year after year as long as customers stay. For a subscription business it is the truest measure of size and momentum, because it strips out one-time noise and shows the durable, repeating base. Confirmation required ARR growth holding toward 16 percent and net revenue retention climbing toward 113 percent. Net revenue retention measures how much more, or less, existing customers spend this year versus last, before any new customers are counted. Above 100 percent means the customers a company already has are spending more over time, the clearest sign a product is becoming more essential rather than more optional. It is the single best gauge of whether a platform is getting stickier. A break was ARR growth falling below 14 percent or retention slipping below 108. And we named the ambiguous middle in advance: retention stuck around 111, growth steady in the mid-teens, a quarter that neither confirms the re-rating nor breaks the thesis. We wrote all three down before the print.

Test 1: ARR growth

Published bar: growth holding toward 16 percent confirms; below 14 percent breaks.

The number: annual recurring revenue reached $2.14 billion, up 17 percent year over year in constant currency, meaning after stripping out the distortion of exchange-rate swings so the underlying growth is what you see. Net new ARR grew 66 percent, with record new-logo wins. Confirms. Growth did not just hold, it came in above the line, driven by the largest new-customer quarter the company has posted. On the growth half of the bar, Dynatrace cleared it cleanly.

Test 2: Net revenue retention

Published bar: retention climbing toward 113 percent confirms the platform is getting stickier; below 108 breaks it.

The number: net revenue retention was 110 percent, down from 111 a quarter earlier, and management said it does not expect improvement until the back half of the year, citing light renewal periods. Ambiguous, and slightly soft. This is the exact case we flagged in advance. Retention did not break, it sits comfortably above the 108 line. But it did not climb toward 113 either. It drifted down a point, and the one number that would prove the platform is deepening its hold on customers stayed stuck, with management telling us to wait two more quarters. This is the crux of the whole Dynatrace story, and it is still unresolved.

Everything else the market claims to want, it got

Non-GAAP operating margin was 29 percent, a point above guidance, which added to 16 percent revenue growth gives what software investors call a Rule of 50 score of 45. That rule adds a company’s revenue growth rate to its profit margin, and a combined score in the 40s or above signals a business that is both growing and profitable rather than buying growth by burning cash. At 45, Dynatrace is closing in on the demanding end of that mark. Adjusted free cash flow was $309 million at a 56 percent margin. The company raised full-year guidance on revenue, ARR, and earnings. And it bought back 7.1 million shares for $275 million during the quarter, at an average under $39, management putting the company’s cash behind the same conviction it asks investors to have.

By almost every measure a value investor cares about, profitability, cash generation, capital discipline, reasonable growth, this was an excellent quarter from a business trading around 22 times forward earnings. Which is the puzzle.

The tally: it confirmed the growth, and left the one question open

So here is the honest grade. On the growth bar, Dynatrace confirmed. On everything ancillary, margins, cash, guidance, buybacks, it was strong to excellent. And on the single number the whole thesis turns on, retention, it landed in the ambiguous zone we named in advance, ticking down to 110 with no improvement promised until later in the year. The business is healthy. The proof that it is getting stickier, the thing that would make the market finally re-rate it, is one more quarter away, at least.

That is not a break. It is not a full confirm. It is the profitable company nobody wants, doing profitable things nobody rewards, because the one number that would force a re-rating stays just out of reach.

The state change: it holds, and so does the puzzle

Dynatrace remains Watch. Nothing broke. But the case for a re-rating rests on retention turning up, and it did not. The valuation is reasonable, the profitability real, the growth fine, and the stock stays unloved because the market wants the platform proven stickier before it pays up, and this quarter did not deliver that proof. A cheap, profitable, growing business with one unproven variable is a Watch that becomes more the moment the variable resolves.

One thing worth flagging, and why

The company announced its CFO plans to resign. We do not grade a leadership transition as a test, and a planned, orderly CFO change at a healthy company is not a red flag on its own. But we note it, because a value investor watches management continuity, and a new CFO is a variable to track, not to panic over. It stays a research item, not a mark against the grade.

Why I own it, and why that does not soften the grade

Here is the personal part, because personalizing this is only honest if it stays truthful. I have owned Dynatrace since September 2022, at $33.21. I bought it then for a specific reason: the company had built its own AI engine, real, proprietary technology, at a time when much of the market was still just talking about AI as a concept. The depth was the draw. I understood what that technology was, the price was defensible for what the business was, and so I bought it and held it. Its larger competitor, Datadog, was a top name in the same space, and it simply was not my focus. I was drawn to the specific edge Dynatrace had built, not to surveying the field.

In the years since, Datadog has been the bigger stock. I will not pretend I made a brilliant call against it, because I was not weighing it. I bought the business I understood, at a price I could defend, and I held it. For what Dynatrace brought to the table, the technology, the profitability, the edge, it was a value at the price. That is the only question a value investor asks: for what this company truly is, is the price a value. For Dynatrace it was, and near 22 times forward earnings today, a version of that question is still open in its favor.

And the story is not over. Dynatrace is not the superstar Datadog has been. But it is still here, still competing, still profitable, and the figures still justify the conviction that bought it. Owning it is exactly why I have to grade it straight, which is why this quarter goes in the record as what it was: growth confirmed, retention still unproven, Watch holds. I do not get a gentler grade for being an owner. Neither does the company.

What we watch next, and when

Retention, above all. The back half of the year is where management says the number should improve. If net revenue retention climbs back toward and past 113, the re-rating case gets real. If it keeps drifting, the profitable company nobody wants may stay exactly that.

Then the CFO transition, for continuity, and the price, because at a reasonable multiple this is the rare case where a good quarter and a fair price already coexist, and the only missing piece is the market’s attention.

We named the one thing before the print: stickiness, proven through retention. Dynatrace confirmed its growth, raised its guidance, and left that one number sitting in the ambiguous middle we drew in advance. The business is doing its job. The proof that would make the market care is still pending. And I will keep holding, and keep grading it straight, until the number resolves one way or the other.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch Cards, the Evidence tool, and the full Research Tracker, including every test we have published and how each one scored, on the companies we own and the ones we do not.

Dynatrace did almost everything right, and the market shrugged, again. For a company priced for perfection, that shrug would be a catastrophe. For the profitable company nobody wants, it is just Tuesday, and the reason it is still, for what it is, a value.

Not investment advice. The subscriber decides.

It was flawless. Revenue grew 36 percent. Retention cleared our line. Guidance went up. And the stock had its worst day on record. This is what priced for perfection really looks like when the bill comes due.

Before Datadog reported, we published a piece called “The Company That Has to Be Perfect Forever,” and we drew two lines in advance. This is the grade against those lines. It is the strangest kind of grade we have run, because the company did everything we said it had to do, and the market punished it anyway. Understanding why is the most valuable thing we can teach you about what a price truly is.

The bar we set, before the number

We said it plainly two weeks ago. At roughly 100 times earnings, Datadog was not being asked to be good. It was being asked to be flawless, without pause, because the excellence was already in the price. So we set the bar where the valuation set it, high.

Confirmation required revenue growth holding at or above 25 percent, with net revenue retention staying north of 120 percent, evidence the AI tailwind was still filling the sails and the moat still widening. A break was growth decelerating below 22 percent or retention slipping below 115. We wrote those numbers down in public, before the print, where we could not move them afterward.

Test 1: Revenue growth

Published bar: growth at or above 25 percent confirms; below 22 percent breaks.

The number: revenue of $1.12 billion, up 36 percent year over year, above the high end of the company’s own guidance. Confirms, and not narrowly. Thirty-six percent is not just clearing the bar, it is clearing it with room to spare. On growth alone, Datadog was firing on every cylinder.

Test 2: Net revenue retention

Published bar: retention above 120 percent confirms the moat is still widening; below 115 breaks it.

The number: trailing net revenue retention in the low 120s, around 122 percent, up from 120 a year ago. Confirms. This was the number we said mattered most, the proof that existing customers keep spending more, that the platform gets stickier rather than merely holding. It did not just stay above our line. It ticked up. The moat widened.

The rest of the print, all of it good

Operating margin expanded to 23 percent, from 20 a year ago. Free cash flow was $279 million. Remaining performance obligations, the contracted future revenue, grew 43 percent. The count of customers worth more than $100,000 a year rose to about 4,720, up 23 percent. And management raised full-year guidance to roughly $4.45 billion, implying about 30 percent growth for the year. By every measure we published and several we did not, this was an excellent quarter from an excellent business.

The company was flawless. The stock fell 17 percent.

On the day, Datadog fell about 17 percent, its worst single day drop on record, worse than anything in the 2020 crash. A company that beat on revenue, beat on earnings, raised guidance, and grew retention lost roughly a sixth of its value in a session.

Read that twice, because it is the entire lesson of this grade, and of the piece we wrote before it. Our bar was a business bar, and the business cleared it cleanly. But the price had set a different bar, an invisible one, and that is the bar that moves the stock. At 100 times earnings, “confirm our published lines” was not the test the market was running. The market’s test was: keep accelerating, forever, with no new risk, no deceleration, no wobble in any single customer. And on that test, this flawless quarter contained two small cracks that at a cheaper price would not have mattered at all.

The two cracks that only matter at this price

First, guidance for next quarter implies growth slowing to 28 or 29 percent, down from this quarter’s 36. Still a spectacular rate. But at a perfection price, deceleration from extraordinary to merely excellent is not good news, it is the first evidence that the fastest days may be behind, and the multiple was built on the fastest days continuing.

Second, Datadog’s largest customer, which it does not name but which analysts widely believe to be OpenAI, reduced its usage, even as it renewed a nine-figure contract during the quarter. Management prudently de-risked its guidance to account for it. At a reasonable valuation, one big customer optimizing spend is a footnote. At this valuation, it is a reminder that a meaningful slice of the hypergrowth rides on a concentrated handful of AI-native accounts whose usage can move, and that concentration is a risk the price had not been treating as a risk. It is not even a new risk: the same story, one large customer optimizing, took a similar bite out of the stock in 2023, and the market repriced it then too, and forgot again.

Neither of these is a broken business. Both are the kind of thing that only becomes a 17 percent problem when the price has left no room for anything less than perfect. That is what priced for perfection means. It is not a phrase. It is a mechanism, and you just watched it fire.

The state change: the bar confirmed, the lesson delivered

So how do we grade a quarter that cleared every line we published and still cratered? Plainly, and precisely. Against our bar, Datadog confirmed. The business is doing what the story promised, growing fast, retaining and expanding customers, widening its moat. We do not get to pretend otherwise just because the stock fell. The lines we drew, it cleared.

But the classification does not improve, and here is why that is not a contradiction. Datadog was never on our watch list because we doubted the business. It was there because of the price. The quarter resolved the business question and left the price question exactly where it was, or rather, the market just answered the price question for us, violently, in the direction we had flagged. The company proved it is excellent. The market proved that excellent is not the same as worth 100 times earnings. Both things are true and holding both in your head at once is the whole discipline.

Datadog stays where it was: a magnificent business we do not own, because the price still asks for more than magnificent. It asks for perfect, forever, and this quarter showed what happens the first time reality falls a hair short of that impossible standard.

What we watch next, and when

Whether the deceleration continues. Q3 will tell us if 28 to 29 percent was conservatism or the start of a trend. At this valuation, the slope matters more than the level.

The AI-native customer concentration. We watch whether more large accounts optimize usage, because the price is carrying an assumption of smooth, uninterrupted expansion that a concentrated customer base can disrupt.

And the price itself, plainly. Datadog fell to around $237 from about $288. That is not our signal to move, it is the market repricing perfection toward merely excellent. If it keeps falling toward a multiple where excellent is enough, this magnificent business finally becomes a value question worth asking. It is not there yet. But for the first time, it is falling in that direction.

We said being wonderful would not be enough at this price, only being flawless-forever would, and even that might crack the first time it was tested. It was flawless. It cleared every line we published. And it fell 17 percent, because the price was never asking for flawless. It was asking for perfect, and perfect has no upside, only the long way down the first time the world notices it is merely excellent.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch Cards, the Evidence tool, and the full Research Tracker, including every test we have published and how each one scored.

Datadog is the best business in its industry. That was never the question. The question was whether the best business is the best stock when it has to be perfect to stay standing, and this week, for one brutal session, the answer was no.

Not investment advice. The subscriber decides.

Chipotle passed every quality test we run, then fell far enough that, for the first time in years, the deep dive is worth starting. This is the piece that comes before the deep dive: whether the price has earned it. It has. Barely, and with a live question attached.

All week we showed the system saying no, fast. Sherwin-Williams beat its quarter and missed the bar its price set. Starbucks proved its turnaround and still costs too much. Both stayed on the watch list, and both saved you the two hours a deep dive would have taken. Today is the other half of the method, the part a filter that only rejects can never show you: a company that made it through.

Chipotle cleared our gauntlet. It passed verification, and it passed the first gates, the business is real, the returns are high, the story holds. That is rare, and it is the reason Chipotle earns a different kind of piece than the other two. But clearing the gauntlet is not the finish line. There is one more gate, and it is the one this whole week has been about. Price sets the height of the bar, and the last question the gauntlet asks is whether the price has fallen far enough to make the deep dive worth doing at all.

The gauntlet is not a buy signal. It is an invitation to look harder.

Here is the distinction almost nobody draws. A company clearing our quality gates does not mean buy it. It means the business is good enough to be worth studying closely, if, and only if, the price gives you a reason to. A wonderful business at an absurd price is not a research priority; it is a company to admire and ignore until the price changes. So the gauntlet advances a company to one final question before any deep dive begins: has the price come to a level where two hours of your life would be well spent. That is the prerequisite, and you do not start the deep dive until it is met. For most of the last decade Chipotle failed it, trading at fifty, sixty, seventy times earnings, a magnificent company at a price that left nothing for the buyer. Something changed this year.

What the price is now

Chipotle has fallen roughly 38% over the past year. It trades near 25 times forward earnings, and about 34 times trailing. Hold those numbers against its own history: the ten-year median trailing multiple is close to 58. The stock sits about 46% below the valuation it has typically commanded. The froth of a decade is gone.

That is what makes this different from Starbucks, which we graded yesterday at forty times earnings, a price still assuming the ending. Chipotle is the opposite motion. This is a high-quality business that the market has truly marked down, not a hopeful one the market is paying up for. And the quality is not in question the way it is at a turnaround. Chipotle earns a return on invested capital above 21%, a return on equity near 49%, and it has been shrinking its share count. These are the numbers of a business that compounds, and they are still intact.

So the prerequisite is close to met. A business that compounds, at 25 times forward earnings and 46% below its own history, is, for the first time in years, priced well enough to be worth the deep dive. Not cheap. Good value, possibly, which is a different and higher standard. We are not looking for a low number. We are looking for a good business at a price that leaves us margin, and those are not the same thing.

The price we are using, and the prices we are not

Because the whole judgment rests on the price, the price has to be honest, with none of the sleight of hand that both the company and the Street use to make a stock look cheaper than it is. So here is exactly what we are counting, and what we are refusing to count.

We are refusing the company’s adjusted earnings. Chipotle, like everyone, will steer you toward figures that strip out the inconvenient parts, the outbreak impact, the one-time costs, the items management would rather you ignore. We value the whole company, ugly quarters included, on real earnings, because you are buying all of it, not the annotated version.

We are treating the forward multiple as a bet, not a fact. The stock looks cheaper on next year’s estimated earnings than on this year’s real earnings, and the entire gap between those two numbers is the Street’s assumption that the margin compression reverses. That assumption is the exact thing in question. So we show both: about 34 times the earnings that exist today, and about 25 times the earnings analysts are projecting if the recovery arrives. The trailing number is what you pay now. The forward number is what you pay if the bet works. Quoting only the forward figure, as most coverage does, quietly assumes the answer.

And we are ignoring two cosmetics. The share price near thirty-four dollars looks small only because of a fifty-for-one split; price per share is meaningless, the multiple is everything. And part of Chipotle’s per-share earnings growth is simply a shrinking share count from buybacks, not the business earning more, so we judge the earning power of the whole enterprise, not the flattered per-share optics.

Strip all of that away and the honest picture holds: a genuine compounder, at roughly 34 times real trailing earnings and 25 times a projected recovery, well below its own decade-long norm but still above its restaurant peers. That is the real price. Whether it is good value depends on the one thing the deep dive has to settle.

But the price fell for a reason, and that is the deep dive’s job

A stock does not drop 38% because the market got generous. It fell because something got worse, and naming that something is what the deep dive exists to do. Chipotle’s most recent quarter is the tell. Comparable sales grew just 2.2%, modest for a company that used to compound at double digits, and underneath, profitability compressed: restaurant-level margin dropped to 25.2% from 27.4% a year earlier, squeezed by beef, freight, and labor. The company beat and raised guidance, the stock jumped double digits on the day, and that applause is exactly what tempts an investor to skip the one question that matters. Is the margin compression cyclical or structural. If cyclical, this is a great business having a hard year at a rare discount, and the deep dive builds the conviction to act. If structural, if costs have permanently reset and Chipotle can no longer price back to prior margins without losing traffic, then the discount is not a discount, it is a fair price for a slower company. Same multiple, two opposite meanings, and only a deep dive resolves which.

And this week added a fresh complication that sharpens the point. A salmonella outbreak in Minnesota was traced to Chipotle, the company pulled jalapenos, and the stock fell about 7% on the news. Food-safety incidents are the one recurring scar in Chipotle’s history, and they matter to the exact question the deep dive must answer, because they hit both the near-term numbers and the long-term brand. Whether this is a contained event or part of a pattern is not something today’s article decides. It is something the deep dive investigates.

Where it sits: the prerequisite is met, the deep dive is earned

Chipotle moves to Clear for Deeper Research, and it is worth being precise about what that does and does not mean. It does not mean buy. It does not mean the margin question is answered, or the outbreak is behind them. It means one specific thing: the price has finally fallen far enough that a high-quality business is worth the two hours a real deep dive takes. For years it was not. Now it is.

That is the whole function of the prerequisite. It is the gate between “good company” and “good company worth studying at this price.” Sherwin cleared the quality bar and failed this gate, too expensive, stay on watch. Starbucks the same. Chipotle is the first company of the week to clear it, not because its business is better than Sherwin’s, but because its price fell and theirs did not. Price set the height of the bar, and Chipotle’s price finally came down to a height worth clearing.

What the deep dive would have to prove, and what would make it a buy

Here is the forward picture, so you know exactly what we are watching for. The deep dive turns into conviction only if three things line up. The margin compression proves cyclical, restaurant-level margin stabilizing and then recovering back toward the high 20s over the next two or three quarters, showing the cost reset was temporary. Comparable sales reaccelerating from the low single digits, proving the brand still pulls traffic and the growth engine is not permanently slower. And the food-safety issue proving contained, no pattern, no lasting dent to the brand that took twenty years to build.

Put those together with a price still near or below today’s 25 times forward, and Chipotle stops being a company we are researching and becomes a wonderful business at a fair price, the only kind we buy. Miss any of them, margins stay compressed, comps stall, or the safety issue recurs, and the discount was not a discount, it was the market correctly pricing a business that changed. We do not know yet which it is. That honesty is the point. The price has earned the deep dive. The deep dive earns the conviction. And we do not skip a single step, because skipping steps at the wrong price is exactly how good investors lose money on great companies.

This is where the week’s method comes full circle. The filter said no to Sherwin and Starbucks in minutes and saved you the hours. It said yes to Chipotle, not “buy,” but “now it is worth the work,” and it said so only because the price finally justified it. That is the whole system in one week: reject fast, advance rarely, and let price decide when a great company is finally worth your time.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch Cards, the Evidence tool, and the full Research Tracker, including every company we are watching and exactly what would move it from watch to work to conviction.

Chipotle cleared the gauntlet. The price earned it the deep dive. Whether it earns the buy is the next question, and it is the one we do not answer until we have done the two hours the price has finally made worth spending.

Not investment advice. The subscriber decides.

Transactions grew, North America comps jumped, margins expanded. Four of our five bars cleared. And the stock still sits at forty times earnings, which is the number that keeps a working turnaround on the watch list.

Before Starbucks reported, we published a scorecard with five bars and classified it Watch, framework Turnaround Analysis. This is the grade against those bars. It is the mirror image of the grade we ran yesterday, and the contrast is the lesson.

We did not have to remember this print was coming

The scorecard carried the date. Starbucks surfaced with all five tests pending and Q3 results due July 29. The calendar lives in the tool.

What the tool told us, and the one thing it named

The Firewall classified Starbucks Watch and named the assumption with unusual precision: investors believe Niccol’s operational changes are stabilizing traffic now, that the comparable-sales declines are bottoming, and that the turnaround is inflecting in the present, not two or three years away. That last part is the whole bet. Everyone agrees Starbucks can eventually be fixed. The price depends on whether it is being fixed right now.

So, the one thing to prove was not “is the plan good.” It was “is the plan working yet, in the numbers, this quarter.” Traffic is the tell, because a turnaround built on operational fixes shows up first as more people walking in the door, before it shows up in anything else.

The bar the price set

Here is the frame we carried all week, and it applies to Starbucks in a way that looks different from Sherwin-Williams but comes from the same place. Starbucks trades around $104, which is roughly forty times forward earnings. That is not a price that asks, “is the turnaround real.” It is a price that assumes the turnaround is largely already won and asks, “does it keep compounding from here.” Forty times earnings set a high bar, because the stock has already priced in a lot of the recovery it is now being asked to deliver.

Starbucks had to do something harder than show a good quarter. It had to show the inflection is truly underway. On that, the quarter delivered.

Test 1 and 2: Is traffic inflecting

Published bars: North America comparable sales growth, and global comparable transaction count growth. Transactions are the purest measure, because they count people, not price.

The numbers: North America comps grew 8.1%. Global comparable transactions grew 4.2%. Both proven.

This is the heart of the grade. The single most important number for an operational turnaround is whether more people are showing up, and they are, transactions up 4.2% globally. This is not price papering over soft demand, the way it was at Sherwin-Williams yesterday. This is real volume, more customers, more visits. The inflection the price is paying for is visible in the one number that matters most.

Test 3: China

Published bar: China comparable sales growth, the second engine of the global story.

The result: the international segment grew comparable sales 5.7%, but Starbucks did not disclose a standalone China comp this quarter, following the restructuring of its China business. The number we specifically wanted is not in the release. Inconclusive.

We do not grade a test the company did not let us see, and we do not infer China’s health from a blended international figure that includes many other markets. This is the one bar of the five that stays open. It is not a failure, and it is not a pass. It is a question the disclosure did not answer, and we leave it open rather than guess, exactly as we would want to be held to.

Test 4: Margins

Published bar: consolidated operating margin moving in the right direction, proof the turnaround is not being bought entirely with discounts and labor.

The number: operating margin was 10.5%, against 9.9% a year ago, up 60 basis points. Proven. The traffic is coming back without margins going backward, which is the harder version of a turnaround and the more durable one.

Test 5: Guidance

Published bar: full-year guidance maintained or raised, management signaling the trajectory is holding.

The result: guidance was raised. Full-year comparable sales growth is now guided to nearing 6%, with the U.S. slightly greater, and non-GAAP EPS to $2.55 to $2.65. Proven.

The tally: four proven, one open, none broken

Sit with the shape, because it is the opposite of yesterday. Sherwin-Williams beat the headline and missed the one thing its price required. Starbucks did the reverse: it proved the one thing its story is built on. Traffic is inflecting, comps are strong, margins are expanding, guidance went up. Four of five bars cleared, and the fifth is not a miss, it is a number the company did not disclose. On the evidence, the turnaround is working.

The number that would settle what is left

The open question is China, and it matters more than one inconclusive test usually would, because China was always the second half of the Starbucks growth story. A turnaround that works in North America and stalls in China is a different, smaller company than the one forty times earnings is pricing. Until Starbucks discloses a clean China comp, that half of the story is unverified, and the price is assuming it resolves well.

Where it sits now: the turnaround cleared the bar, the price did not

Here is why a quarter this good does not change the classification. Starbucks trades near forty times forward earnings. The business proved its turnaround is real, but the price is not asking whether the turnaround is real. It is asking whether the turnaround is real, and continues, and reaccelerates in China, and grows into a multiple that already assumes most of that. A working turnaround at a fair price is a buy. A working turnaround at forty times, with the dividend currently covered by less than one times free cash flow, is a company doing everything right at a price that leaves you no room if anything goes less than right.

That is the price setting the height of the bar again. At twenty-five times, the quarter Starbucks just printed might clear it outright. At forty times, the same quarter is necessary but not sufficient, because the multiple has already spent the good news.

The state change

Starbucks moves within Watch, and it is an honest hold with a better reason than most. It does not advance to Clear for Deeper Research, for two reasons that have nothing to do with the quality of the quarter: China is unverified, and the price offers no margin of safety. It does not fall back, because the core assumption, traffic inflecting now, proved out clearly. This is a turnaround we would truly like to own, held back by a number, the price, and a missing disclosure, China. When one of those two moves, the classification moves with it.

One thing we did not grade, and why

We did not grade the dividend’s durability, though it deserves a flag. Free cash flow covered the dividend less than fully last year, and the payout has run ahead of earnings during the fix. That is not a break, turnarounds routinely run tight on cash while they invest, but it is a line to watch, because a streak the market values is being funded through a lean period. We hold it as a research item, not a graded test.

What we watch next, and when

A disclosed China comparable-sales number, which would close the one open bar and tell us whether the second engine is running or stalled.

Then the price, plainly. The turnaround does not need to prove much more. It needs either more time to grow into the multiple, or a lower multiple to grow into. The business is doing its part. The valuation is the part that has to give.

We named the one thing before the print: traffic inflecting now. It did. Four bars cleared, one stayed open because the company did not disclose it, and none broke. The turnaround is real. And the classification stays Watch anyway, because at forty times earnings the price already assumes the ending, and a value investor does not pay the ending price for a story still in its middle.

Run any company through the Stock Story Firewall, free, at firewall.readthelongview.com. Subscribers get the Watch Cards, the Evidence tool, and the full Research Tracker, including every test we have published and how each one scored.

Starbucks proved the turnaround is working. That is not the same as proving the stock is worth forty times earnings, and the difference between those two sentences is the entire reason we grade against the bar the price sets.

Not investment advice. The subscriber decides.